{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:35:37Z","timestamp":1793320537670,"version":"4.5.0"},"reference-count":293,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00125-021-05568-3","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T20:20:53Z","timestamp":1632946853000},"page":"2609-2652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":362,"title":["The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)"],"prefix":"10.1007","volume":"64","author":[{"given":"Richard I. G.","family":"Holt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Hans","family":"DeVries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Hess-Fischl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irl B.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Sue","family":"Kirkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Klupa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"N\u00f8rgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Pettus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Renard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay S.","family":"Skyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Snoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth S.","family":"Weinstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"issue":"11","key":"5568_CR1","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.2337\/db11-1625","volume":"61","author":"RG Miller","year":"2012","unstructured":"Miller RG, Secrest AM, Sharma RK, Songer TJ, Orchard TJ (2012) Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort. Diabetes. 61(11):2987\u20132992. https:\/\/doi.org\/10.2337\/db11-1625","journal-title":"Diabetes."},{"issue":"2","key":"5568_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.34172\/hpp.2020.18","volume":"10","author":"M Mobasseri","year":"2020","unstructured":"Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M (2020) Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot Perspect 10(2):98\u2013115. https:\/\/doi.org\/10.34172\/hpp.2020.18","journal-title":"Health Promot Perspect"},{"issue":"5","key":"5568_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1210\/endrev\/bnaa015","volume":"41","author":"IB Hirsch","year":"2020","unstructured":"Hirsch IB, Juneja R, Beals JM, Antalis CJ, Wright EE (2020) The evolution of insulin and how it informs therapy and treatment choices. Endocr Rev 41(5):733\u2013755. https:\/\/doi.org\/10.1210\/endrev\/bnaa015","journal-title":"Endocr Rev"},{"issue":"8","key":"5568_CR4","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2337\/dbi18-0002","volume":"67","author":"AM Stamatouli","year":"2018","unstructured":"Stamatouli AM, Quandt Z, Perdigoto AL et al (2018) Collateral damage: insulin-dependent diabetes induced with checkpoint inhibitors. Diabetes. 67(8):1471\u20131480. https:\/\/doi.org\/10.2337\/dbi18-0002","journal-title":"Diabetes."},{"issue":"3","key":"5568_CR5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2337\/dc14-1952","volume":"38","author":"AK Davis","year":"2015","unstructured":"Davis AK, DuBose SN, Haller MJ et al (2015) Prevalence of detectable C-peptide according to age at diagnosis and duration of type 1 diabetes. Diabetes Care 38(3):476\u2013481. https:\/\/doi.org\/10.2337\/dc14-1952","journal-title":"Diabetes Care"},{"issue":"7","key":"5568_CR6","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s00125-019-4863-8","volume":"62","author":"NJ Thomas","year":"2019","unstructured":"Thomas NJ, Lynam AL, Hill AV et al (2019) Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes. Diabetologia. 62(7):1167\u20131172. https:\/\/doi.org\/10.1007\/s00125-019-4863-8","journal-title":"Diabetologia."},{"issue":"3","key":"5568_CR7","doi-asserted-by":"publisher","first-page":"276","DOI":"10.2337\/cd18-0088","volume":"37","author":"C Mu\u00f1oz","year":"2019","unstructured":"Mu\u00f1oz C, Floreen A, Garey C et al (2019) Misdiagnosis and diabetic ketoacidosis at diagnosis of type 1 diabetes: patient and caregiver perspectives. Clin Diabetes 37(3):276\u2013281. https:\/\/doi.org\/10.2337\/cd18-0088","journal-title":"Clin Diabetes"},{"issue":"646","key":"5568_CR8","doi-asserted-by":"publisher","first-page":"e315","DOI":"10.3399\/bjgp16X684961","volume":"66","author":"SV Hope","year":"2016","unstructured":"Hope SV, Wienand-Barnett S, Shepherd M et al (2016) Practical classification guidelines for diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis. Br J Gen Pract 66(646):e315\u2013e322. https:\/\/doi.org\/10.3399\/bjgp16X684961","journal-title":"Br J Gen Pract"},{"issue":"11","key":"5568_CR9","doi-asserted-by":"publisher","first-page":"e009088","DOI":"10.1136\/bmjopen-2015-009088","volume":"5","author":"BM Shields","year":"2015","unstructured":"Shields BM, Peters JL, Cooper C et al (2015) Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature. BMJ Open 5(11):e009088. https:\/\/doi.org\/10.1136\/bmjopen-2015-009088","journal-title":"BMJ Open"},{"key":"5568_CR10","unstructured":"Jones AG, Hill AV, Trippett PW, Hattersley AT, McDonald TJ, Shields BM (2019). The utility of clinical features and glycaemia at diagnosis in classifying young adult onset diabetes (Abstract). Available from: www.easd.org\/virtualmeeting\/home.html#!resources\/the-utility-of-clinical-features-and-glycaemia-at-diagnosis-in-classifying-young-adult-onset-diabetes. Accessed 23 August 2021"},{"issue":"2","key":"5568_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S2213-8587(17)30362-5","volume":"6","author":"NJ Thomas","year":"2018","unstructured":"Thomas NJ, Jones SE, Weedon MN, Shields BM, Oram RA, Hattersley AT (2018) Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. Lancet Diabetes Endocrinol 6(2):122\u2013129. https:\/\/doi.org\/10.1016\/S2213-8587(17)30362-5","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"5568_CR12","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.2337\/diacare.24.9.1522","volume":"24","author":"TA Hillier","year":"2001","unstructured":"Hillier TA, Pedula KL (2001) Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care 24(9):1522\u20131527. https:\/\/doi.org\/10.2337\/diacare.24.9.1522","journal-title":"Diabetes Care"},{"issue":"1","key":"5568_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0002-9343(96)00076-9","volume":"101","author":"SA Westphal","year":"1996","unstructured":"Westphal SA (1996) The occurrence of diabetic ketoacidosis in non-insulin-dependent diabetes and newly diagnosed diabetic adults. Am J Med 101(1):19\u201324. https:\/\/doi.org\/10.1016\/S0002-9343(96)00076-9","journal-title":"Am J Med"},{"issue":"8","key":"5568_CR14","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00125-003-1158-9","volume":"46","author":"T Nakagami","year":"2003","unstructured":"Nakagami T, Qiao Q, Carstensen B et al (2003) Age, body mass index and type 2 diabetes-associations modified by ethnicity. Diabetologia. 46(8):1063\u20131070. https:\/\/doi.org\/10.1007\/s00125-003-1158-9","journal-title":"Diabetologia."},{"issue":"1","key":"5568_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/1047-2797(93)90004-N","volume":"3","author":"MJ Prior","year":"1993","unstructured":"Prior MJ, Prout T, Miller D, Ewart R, Kumar D (1993) The ETDRS Research Group. C-peptide and the classification of diabetes mellitus patients in the Early Treatment Diabetic Retinopathy Study. Report number 6. Ann Epidemiol 3(1):9\u201317. https:\/\/doi.org\/10.1016\/1047-2797(93)90004-N","journal-title":"Ann Epidemiol"},{"key":"5568_CR16","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s00125-020-05181-w","volume":"63","author":"WK Chung","year":"2020","unstructured":"Chung WK, Erion K, Florez JC et al (2020) Precision medicine in diabetes: a consensus report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 63:1671\u20131693. https:\/\/doi.org\/10.1007\/s00125-020-05181-w","journal-title":"Diabetologia."},{"issue":"10","key":"5568_CR17","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.2337\/dbi20-0017","volume":"69","author":"R Buzzetti","year":"2020","unstructured":"Buzzetti R, Tuomi T, Mauricio D et al (2020) Management of latent autoimmune diabetes in adults: a consensus statement from an international expert panel. Diabetes. 69(10):2037\u20132047. https:\/\/doi.org\/10.2337\/dbi20-0017","journal-title":"Diabetes."},{"issue":"8","key":"5568_CR18","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2337\/dc17-0224","volume":"40","author":"BM Shields","year":"2017","unstructured":"Shields BM, Shepherd M, Hudson M et al (2017) Population-based assessment of a biomarker-based screening pathway to aid diagnosis of monogenic diabetes in young-onset patients. Diabetes Care 40(8):1017\u20131025. https:\/\/doi.org\/10.2337\/dc17-0224","journal-title":"Diabetes Care"},{"issue":"9392","key":"5568_CR19","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0140-6736(03)14571-0","volume":"362","author":"ER Pearson","year":"2003","unstructured":"Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT (2003) Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet. 362(9392):1275\u20131281. https:\/\/doi.org\/10.1016\/S0140-6736(03)14571-0","journal-title":"Lancet."},{"issue":"S27","key":"5568_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/pedi.12772","volume":"19","author":"AT Hattersley","year":"2018","unstructured":"Hattersley AT, Greeley SAW, Polak M et al (2018) ISPAD clinical practice consensus guidelines 2018: the diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes 19(S27):47\u201363","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"5568_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1210\/jc.2009-1365","volume":"95","author":"PJ Bingley","year":"2010","unstructured":"Bingley PJ (2010) Clinical applications of diabetes antibody testing. J Clin Endocrinol Metab 95(1):25\u201333. https:\/\/doi.org\/10.1210\/jc.2009-1365","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"5568_CR22","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.2337\/diacare.23.9.1326","volume":"23","author":"E Sabbah","year":"2000","unstructured":"Sabbah E, Savola K, Ebeling T et al (2000) Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes. Diabetes Care 23(9):1326\u20131332. https:\/\/doi.org\/10.2337\/diacare.23.9.1326","journal-title":"Diabetes Care"},{"issue":"3","key":"5568_CR23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2337\/diacare.22.3.409","volume":"22","author":"B Littorin","year":"1999","unstructured":"Littorin B, Sundkvist G, Hagopian W et al (1999) Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes. Diabetes Care 22(3):409\u2013412. https:\/\/doi.org\/10.2337\/diacare.22.3.409","journal-title":"Diabetes Care"},{"issue":"9","key":"5568_CR24","doi-asserted-by":"publisher","first-page":"e031586","DOI":"10.1136\/bmjopen-2019-031586","volume":"9","author":"A Lynam","year":"2019","unstructured":"Lynam A, McDonald T, Hill A et al (2019) Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 years. BMJ Open 9(9):e031586. https:\/\/doi.org\/10.1136\/bmjopen-2019-031586","journal-title":"BMJ Open"},{"key":"5568_CR25","doi-asserted-by":"publisher","unstructured":"Thomas NJ, Walkey HC, Kaur A et al (2021) The absence of islet autoantibodies in clinically diagnosed older-adult onset type 1 diabetes suggests an alternative pathology, advocating for routine testing in this age group. medRxiv 2021.03.22.21252507 (Preprint). 24 Mar 2021. Available from: https:\/\/doi.org\/10.1101\/2021.03.22.21252507. Accessed 23 August 2021","DOI":"10.1101\/2021.03.22.21252507"},{"issue":"4","key":"5568_CR26","doi-asserted-by":"publisher","first-page":"988","DOI":"10.2337\/dc10-1903","volume":"34","author":"DM Tridgell","year":"2011","unstructured":"Tridgell DM, Spiekerman C, Wang RS, Greenbaum CJ (2011) Interaction of onset and duration of diabetes on the percent of GAD and IA-2 antibody-positive subjects in the type 1 diabetes genetics consortium database. Diabetes Care 34(4):988\u2013993. https:\/\/doi.org\/10.2337\/dc10-1903","journal-title":"Diabetes Care"},{"issue":"12","key":"5568_CR27","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.2337\/dc06-0749","volume":"29","author":"A Balasubramanyam","year":"2006","unstructured":"Balasubramanyam A, Garza G, Rodriguez L et al (2006) Accuracy and predictive value of classification schemes for ketosis-prone diabetes. Diabetes Care 29(12):2575\u20132579. https:\/\/doi.org\/10.2337\/dc06-0749","journal-title":"Diabetes Care"},{"issue":"5","key":"5568_CR28","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1463-1326.2008.00975.x","volume":"11","author":"C Hohberg","year":"2009","unstructured":"Hohberg C, Pf\u00fctzner A, Forst T et al (2009) Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual beta-cell function: results from the PioSwitch study. Diabetes Obes Metab 11(5):464\u2013471. https:\/\/doi.org\/10.1111\/j.1463-1326.2008.00975.x","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"5568_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4158\/EP.5.6.305","volume":"5","author":"A Lee","year":"1999","unstructured":"Lee A, Morley J (1999) Classification of type 2 diabetes by clinical response to metformin-troglitazone combination and C-peptide criteria. Endocr Pract 5(6):305\u2013313. https:\/\/doi.org\/10.4158\/EP.5.6.305","journal-title":"Endocr Pract"},{"issue":"2","key":"5568_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4158\/EP.4.2.82","volume":"4","author":"DS Bell","year":"1998","unstructured":"Bell DS, Mayo MS (1998) Improved glycemic control with use of oral hypoglycemic therapy with or without insulin. Endocr Pract 4(2):82\u201385. https:\/\/doi.org\/10.4158\/EP.4.2.82","journal-title":"Endocr Pract"},{"key":"5568_CR31","doi-asserted-by":"crossref","first-page":"e14449","DOI":"10.1111\/dme.14449","volume":"38","author":"E Foteinopoulou","year":"2020","unstructured":"Foteinopoulou E, Clarke CAL, Pattenden RJ et al (2020) Impact of routine clinic measurement of serum C-peptide in people with a clinician-diagnosis of type 1 diabetes. Diabet Med 38:e14449","journal-title":"Diabet Med"},{"issue":"9997","key":"5568_CR32","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)60098-8","volume":"386","author":"E De Franco","year":"2015","unstructured":"De Franco E, Flanagan SE, Houghton JAL et al (2015) The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study. Lancet. 386(9997):957\u2013963. https:\/\/doi.org\/10.1016\/S0140-6736(15)60098-8","journal-title":"Lancet."},{"issue":"5","key":"5568_CR33","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1056\/NEJMoa061759","volume":"355","author":"ER Pearson","year":"2006","unstructured":"Pearson ER, Flechtner I, Nj\u00f8lstad PR et al (2006) Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355(5):467\u2013477. https:\/\/doi.org\/10.1056\/NEJMoa061759","journal-title":"N Engl J Med"},{"issue":"1","key":"5568_CR34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2337\/dc19-0747","volume":"43","author":"A Carlsson","year":"2020","unstructured":"Carlsson A, Shepherd M, Ellard S et al (2020) Absence of islet autoantibodies and modestly raised glucose values at diabetes diagnosis should lead to testing for MODY: lessons from a 5-year pediatric Swedish National Cohort Study. Diabetes Care 43(1):82\u201389","journal-title":"Diabetes Care"},{"issue":"5","key":"5568_CR35","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00125-011-2418-8","volume":"55","author":"BM Shields","year":"2012","unstructured":"Shields BM, McDonald TJ, Ellard S, Campbell MJ, Hyde C, Hattersley AT (2012) The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia. 55(5):1265\u20131272. https:\/\/doi.org\/10.1007\/s00125-011-2418-8","journal-title":"Diabetologia."},{"issue":"2","key":"5568_CR36","doi-asserted-by":"publisher","first-page":"286","DOI":"10.2337\/dc10-1293","volume":"34","author":"REJ Besser","year":"2011","unstructured":"Besser REJ, Shepherd MH, McDonald TJ et al (2011) Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-\u03b1\/hepatocyte nuclear factor 4-\u03b1 maturity-onset diabetes of the young from long-duration type 1 diabetes. Diabetes Care 34(2):286\u2013291. https:\/\/doi.org\/10.2337\/dc10-1293","journal-title":"Diabetes Care"},{"issue":"9","key":"5568_CR37","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/j.1464-5491.2011.03287.x","volume":"28","author":"TJ McDonald","year":"2011","unstructured":"McDonald TJ, Colclough K, Brown R et al (2011) Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from type 1 diabetes. Diabet Med 28(9):1028\u20131033. https:\/\/doi.org\/10.1111\/j.1464-5491.2011.03287.x","journal-title":"Diabet Med"},{"issue":"6","key":"5568_CR38","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.2337\/dc11-1243","volume":"35","author":"G Thanabalasingham","year":"2012","unstructured":"Thanabalasingham G, Pal A, Selwood MP et al (2012) Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young. Diabetes Care 35(6):1206\u20131212. https:\/\/doi.org\/10.2337\/dc11-1243","journal-title":"Diabetes Care"},{"issue":"14","key":"5568_CR39","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","unstructured":"The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329(14):977\u2013986. https:\/\/doi.org\/10.1056\/NEJM199309303291401","journal-title":"N Engl J Med"},{"issue":"5","key":"5568_CR40","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2337\/dc15-1990","volume":"39","author":"The Diabetes Control and Complications Trial (DCCT)\/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group","year":"2016","unstructured":"The Diabetes Control and Complications Trial (DCCT)\/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group (2016) Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT\/EDIC study 30-year follow-up. Diabetes Care 39(5):686\u2013693. https:\/\/doi.org\/10.2337\/dc15-1990","journal-title":"Diabetes Care"},{"issue":"8","key":"5568_CR41","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1210\/jc.2013-1589","volume":"98","author":"RS Weinstock","year":"2013","unstructured":"Weinstock RS, Xing D, Maahs DM et al (2013) Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. J Clin Endocrinol Metab 98(8):3411\u20133419. https:\/\/doi.org\/10.1210\/jc.2013-1589","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"5568_CR42","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1056\/NEJMoa0805017","volume":"359","author":"The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group","year":"2008","unstructured":"The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2008) Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 359(14):1464\u20131476. https:\/\/doi.org\/10.1056\/NEJMoa0805017","journal-title":"N Engl J Med"},{"issue":"10057","key":"5568_CR43","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/S0140-6736(16)31535-5","volume":"388","author":"J Bolinder","year":"2016","unstructured":"Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kr\u00f6ger J, Weitgasser R (2016) Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 388(10057):2254\u20132263. https:\/\/doi.org\/10.1016\/S0140-6736(16)31535-5","journal-title":"Lancet."},{"issue":"11","key":"5568_CR44","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S2213-8587(16)30193-0","volume":"4","author":"CAJ van Beers","year":"2016","unstructured":"van Beers CAJ, DeVries JH, Kleijer SJ et al (2016) Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. Lancet Diabetes Endocrinol 4(11):893\u2013902. https:\/\/doi.org\/10.1016\/S2213-8587(16)30193-0","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"5568_CR45","doi-asserted-by":"publisher","first-page":"400","DOI":"10.2337\/dc18-1444","volume":"42","author":"RW Beck","year":"2019","unstructured":"Beck RW, Bergenstal RM, Riddlesworth TD et al (2019) Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care 42(3):400\u2013405. https:\/\/doi.org\/10.2337\/dc18-1444","journal-title":"Diabetes Care"},{"issue":"11","key":"5568_CR46","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.2337\/dc20-0909","volume":"43","author":"AG Ranjan","year":"2020","unstructured":"Ranjan AG, Rosenlund SV, Hansen TW, Rossing P, Andersen S, N\u00f8rgaard K (2020) Improved time in range over 1 year is associated with reduced albuminuria in individuals with sensor-augmented insulin pump-treated type 1 diabetes. Diabetes Care 43(11):2882\u20132885. https:\/\/doi.org\/10.2337\/dc20-0909","journal-title":"Diabetes Care"},{"issue":"8","key":"5568_CR47","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM et al (2019) Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care 42(8):1593\u20131603. https:\/\/doi.org\/10.2337\/dci19-0028","journal-title":"Diabetes Care"},{"issue":"6","key":"5568_CR48","doi-asserted-by":"publisher","first-page":"996","DOI":"10.2337\/dc15-2450","volume":"39","author":"C Hero","year":"2016","unstructured":"Hero C, Rawshani A, Svensson A-M et al (2016) Association between use of lipid-lowering therapy and cardiovascular diseases and death in individuals with type 1 diabetes. Diabetes Care 39(6):996\u20131003. https:\/\/doi.org\/10.2337\/dc15-2450","journal-title":"Diabetes Care"},{"issue":"11","key":"5568_CR49","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCULATIONAHA.115.018844","volume":"133","author":"D Vistisen","year":"2016","unstructured":"Vistisen D, Andersen GS, Hansen CS et al (2016) Prediction of first cardiovascular disease event in type 1 Diabetes mellitus: the Steno type 1 risk engine. Circulation. 133(11):1058\u20131066. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.018844","journal-title":"Circulation."},{"key":"5568_CR50","unstructured":"ClinRisk (2018) Welcome to the QRISK\u00ae3-2018 risk calculator https:\/\/qrisk.org\/three. Available from: https:\/\/qrisk.org\/three\/index.php. Accessed 16 July 2021"},{"key":"5568_CR51","unstructured":"McGurnaghan SJ, McKeigue PM, Read SH et al (2021) CVD risk prediction T1D. Available from: https:\/\/diabepi.shinyapps.io\/cvdrisk\/. Accessed 16 July 2021"},{"key":"5568_CR52","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2021) 4. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes\u20142021. Diabetes Care 44(Supp 1):S40\u2013S52","DOI":"10.2337\/dc21-S004"},{"issue":"Suppl 1","key":"5568_CR53","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.2337\/dc21-S007","volume":"44","author":"American Diabetes Association","year":"2021","unstructured":"American Diabetes Association (2021) 7. Diabetes technology: standards of medical care in diabetes-2021. Diabetes Care 44(Suppl 1):S85\u2013S99. https:\/\/doi.org\/10.2337\/dc21-S007","journal-title":"Diabetes Care"},{"issue":"2","key":"5568_CR54","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.dsx.2019.02.014","volume":"13","author":"TM Borries","year":"2019","unstructured":"Borries TM, Dunbar A, Bhukhen A et al (2019) The impact of telemedicine on patient self-management processes and clinical outcomes for patients with types I or II diabetes mellitus in the United States: a scoping review. Diabetes Metab Syndr 13(2):1353\u20131357","journal-title":"Diabetes Metab Syndr"},{"issue":"7","key":"5568_CR55","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1089\/dia.2018.0098","volume":"20","author":"JY Lee","year":"2018","unstructured":"Lee JY, Lee SWH (2018) Telemedicine cost-effectiveness for diabetes management: a systematic review. Diabetes Technol Ther 20(7):492\u2013500. https:\/\/doi.org\/10.1089\/dia.2018.0098","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"5568_CR56","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1089\/tmj.2018.0128","volume":"25","author":"H Tchero","year":"2019","unstructured":"Tchero H, Kangambega P, Briatte C, Brunet-Houdard S, Retali G-R, Rusch E (2019) Clinical effectiveness of telemedicine in diabetes mellitus: a meta-analysis of 42 randomized controlled trials. Telemed J E Health 25(7):569\u2013583. https:\/\/doi.org\/10.1089\/tmj.2018.0128","journal-title":"Telemed J E Health"},{"issue":"3","key":"5568_CR57","doi-asserted-by":"publisher","first-page":"e16791","DOI":"10.2196\/16791","volume":"22","author":"P Timpel","year":"2020","unstructured":"Timpel P, Oswald S, Schwarz PEH, Harst L (2020) Mapping the evidence on the effectiveness of telemedicine interventions in diabetes, dyslipidemia, and hypertension: an umbrella review of systematic reviews and meta-analyses. J Med Internet Res 22(3):e16791. https:\/\/doi.org\/10.2196\/16791","journal-title":"J Med Internet Res"},{"issue":"2","key":"5568_CR58","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S2213-8587(17)30260-7","volume":"6","author":"DC Duke","year":"2018","unstructured":"Duke DC, Barry S, Wagner DV, Speight J, Choudhary P, Harris MA (2018) Distal technologies and type 1 diabetes management. Lancet Diabetes Endocrinol 6(2):143\u2013156. https:\/\/doi.org\/10.1016\/S2213-8587(17)30260-7","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"5568_CR59","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1089\/dia.2020.0042","volume":"22","author":"S Crossen","year":"2020","unstructured":"Crossen S, Raymond J, Neinstein A (2020) Top 10 tips for successfully implementing a diabetes telehealth program. Diabetes Technol Ther 22(12):920\u2013928. https:\/\/doi.org\/10.1089\/dia.2020.0042","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"5568_CR60","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.2337\/dci17-0025","volume":"40","author":"J Beck","year":"2017","unstructured":"Beck J, Greenwood DA, Blanton L et al (2017) 2017 national standards for diabetes self-management education and support. Diabetes Care 40(10):1409\u20131419. https:\/\/doi.org\/10.2337\/dci17-0025","journal-title":"Diabetes Care"},{"key":"5568_CR61","unstructured":"Diabetes UK (2021). Diabetes self-management education. Available from: www.diabetes.org.uk\/professionals\/resources\/resources-to-improve-your-clinical-practice\/diabetes-self-management-education. Accessed 11 February 2021"},{"issue":"6","key":"5568_CR62","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1177\/1932296819834054","volume":"13","author":"M Joubert","year":"2019","unstructured":"Joubert M, Benhamou P-Y, Schaepelynck P et al (2019) Remote monitoring of diabetes: a cloud-connected digital system for individuals with diabetes and their health care providers. J Diabetes Sci Technol 13(6):1161\u20131168. https:\/\/doi.org\/10.1177\/1932296819834054","journal-title":"J Diabetes Sci Technol"},{"issue":"7","key":"5568_CR63","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.2337\/dci20-0023","volume":"43","author":"MA Powers","year":"2020","unstructured":"Powers MA, Bardsley JK, Cypress M et al (2020) Diabetes self-management education and support in adults with type 2 diabetes: a consensus report of the American Diabetes Association, the Association of Diabetes Care & Education Specialists, the Academy of Nutrition and Dietetics, the American Academy of Family Physicians, the American Academy of PAs, the American Association of Nurse Practitioners, and the American Pharmacists Association. Diabetes Care 43(7):1636\u20131649","journal-title":"Diabetes Care"},{"issue":"2","key":"5568_CR64","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S2213-8587(17)30239-5","volume":"6","author":"S Chatterjee","year":"2018","unstructured":"Chatterjee S, Davies MJ, Heller S, Speight J, Snoek FJ, Khunti K (2018) Diabetes structured self-management education programmes: a narrative review and current innovations. Lancet Diabetes Endocrinol 6(2):130\u2013142. https:\/\/doi.org\/10.1016\/S2213-8587(17)30239-5","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"5568_CR65","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00125-019-05034-1","volume":"63","author":"GA Fleming","year":"2020","unstructured":"Fleming GA, Petrie JR, Bergenstal RM, Holl RW, Peters AL, Heinemann L (2020) Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group. Diabetologia. 63(2):229\u2013241. https:\/\/doi.org\/10.1007\/s00125-019-05034-1","journal-title":"Diabetologia."},{"issue":"8","key":"5568_CR66","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.2337\/dc08-0545","volume":"31","author":"DM Nathan","year":"2008","unstructured":"Nathan DM, Kuenen J, Borg R et al (2008) Translating the A1C assay into estimated average glucose values. Diabetes Care 31(8):1473\u20131478. https:\/\/doi.org\/10.2337\/dc08-0545","journal-title":"Diabetes Care"},{"issue":"2","key":"5568_CR67","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11606-013-2595-x","volume":"29","author":"MS Radin","year":"2014","unstructured":"Radin MS (2014) Pitfalls in hemoglobin A1c measurement: when results may be misleading. J Gen Intern Med 29(2):388\u2013394. https:\/\/doi.org\/10.1007\/s11606-013-2595-x","journal-title":"J Gen Intern Med"},{"issue":"8","key":"5568_CR68","doi-asserted-by":"publisher","first-page":"994","DOI":"10.2337\/dc17-0636","volume":"40","author":"RW Beck","year":"2017","unstructured":"Beck RW, Connor CG, Mullen DM, Wesley DM, Bergenstal RM (2017) The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading. Diabetes Care 40(8):994\u2013999. https:\/\/doi.org\/10.2337\/dc17-0636","journal-title":"Diabetes Care"},{"issue":"4","key":"5568_CR69","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1177\/1932296818822496","volume":"13","author":"RW Beck","year":"2019","unstructured":"Beck RW, Bergenstal RM, Cheng P et al (2019) The relationships between time in range, hyperglycemia metrics, and HbA1c. J Diabetes Sci Technol 13(4):614\u2013626. https:\/\/doi.org\/10.1177\/1932296818822496","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"5568_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4239\/wjd.v10.i1.1","volume":"10","author":"M Krha\u010d","year":"2019","unstructured":"Krha\u010d M, Lovren\u010di\u0107 MV (2019) Update on biomarkers of glycemic control. World J Diabetes 10(1):1\u201315. https:\/\/doi.org\/10.4239\/wjd.v10.i1.1","journal-title":"World J Diabetes"},{"issue":"7","key":"5568_CR71","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.2337\/dc12-1770","volume":"36","author":"KM Miller","year":"2013","unstructured":"Miller KM, Beck RW, Bergenstal RM et al (2013) Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care 36(7):2009\u20132014. https:\/\/doi.org\/10.2337\/dc12-1770","journal-title":"Diabetes Care"},{"issue":"10","key":"5568_CR72","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.2337\/diacare.28.10.2361","volume":"28","author":"BW Bode","year":"2005","unstructured":"Bode BW, Schwartz S, Stubbs HA, Block JE (2005) Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values. Diabetes Care 28(10):2361\u20132366. https:\/\/doi.org\/10.2337\/diacare.28.10.2361","journal-title":"Diabetes Care"},{"issue":"6","key":"5568_CR73","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1001\/archinte.166.6.689","volume":"166","author":"EC Moreland","year":"2006","unstructured":"Moreland EC, Volkening LK, Lawlor MT, Chalmers KA, Anderson BJ, Laffel LMB (2006) Use of a blood glucose monitoring manual to enhance monitoring adherence in adults with diabetes: a randomized controlled trial. Arch Intern Med 166(6):689\u2013695. https:\/\/doi.org\/10.1001\/archinte.166.6.689","journal-title":"Arch Intern Med"},{"key":"5568_CR74","volume-title":"Diabetes technology: science and practice","author":"B Draznin","year":"2019","unstructured":"Draznin B (2019) Diabetes technology: science and practice. American Diabetes Association, Alexandria, VA"},{"issue":"8","key":"5568_CR75","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.2337\/dc17-1960","volume":"41","author":"DC Klonoff","year":"2018","unstructured":"Klonoff DC, Parkes JL, Kovatchev BP et al (2018) Investigation of the accuracy of 18 marketed blood glucose monitors. Diabetes Care 41(8):1681\u20131688. https:\/\/doi.org\/10.2337\/dc17-1960","journal-title":"Diabetes Care"},{"issue":"4","key":"5568_CR76","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/jama.2016.19975","volume":"317","author":"RW Beck","year":"2017","unstructured":"Beck RW, Riddlesworth T, Ruedy K et al (2017) Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA 317(4):371\u2013378. https:\/\/doi.org\/10.1001\/jama.2016.19975","journal-title":"JAMA."},{"issue":"10291","key":"5568_CR77","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/S0140-6736(21)00789-3","volume":"397","author":"MM Visser","year":"2021","unstructured":"Visser MM, Charleer S, Fieuws S et al (2021) Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial. Lancet. 397(10291):2275\u20132283. https:\/\/doi.org\/10.1016\/S0140-6736(21)00789-3","journal-title":"Lancet."},{"issue":"23","key":"5568_CR78","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1001\/jama.2020.6928","volume":"323","author":"RE Pratley","year":"2020","unstructured":"Pratley RE, Kanapka LG, Rickels MR, Ahmann A, Aleppo G, Beck R et al (2020) Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial. JAMA 323(23):2397\u20132406. https:\/\/doi.org\/10.1001\/jama.2020.6928","journal-title":"JAMA"},{"issue":"3","key":"5568_CR79","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1089\/dia.2013.0051","volume":"15","author":"RM Bergenstal","year":"2013","unstructured":"Bergenstal RM, Ahmann AJ, Bailey T et al (2013) Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther 15(3):198\u2013211. https:\/\/doi.org\/10.1089\/dia.2013.0051","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"5568_CR80","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2337\/ds20-0090","volume":"34","author":"RW Beck","year":"2021","unstructured":"Beck RW, Bergenstal RM (2021) Beyond A1C-standardization of continuous glucose monitoring reporting: why it is needed and how it continues to evolve. Diabetes Spectr 34(2):102\u2013108. https:\/\/doi.org\/10.2337\/ds20-0090","journal-title":"Diabetes Spectr"},{"issue":"10","key":"5568_CR81","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1089\/dia.2019.0171","volume":"21","author":"S Pleus","year":"2019","unstructured":"Pleus S, Ulbrich S, Zschornack E, Kamann S, Haug C, Freckmann G (2019) Documentation of skin-related issues associated with continuous glucose monitoring use in the scientific literature. Diabetes Technol Ther 21(10):538\u2013545. https:\/\/doi.org\/10.1089\/dia.2019.0171","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"5568_CR82","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/cod.13529","volume":"83","author":"A Herman","year":"2020","unstructured":"Herman A, de Montjoye L, Baeck M (2020) Adverse cutaneous reaction to diabetic glucose sensors and insulin pumps: irritant contact dermatitis or allergic contact dermatitis? Contact Dermatitis 83(1):25\u201330. https:\/\/doi.org\/10.1111\/cod.13529","journal-title":"Contact Dermatitis"},{"issue":"4","key":"5568_CR83","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1177\/1932296820918894","volume":"15","author":"RS Rigo","year":"2020","unstructured":"Rigo RS, Levin LE, Belsito DV, Garzon MC, Gandica R, Williams KM (2020) Cutaneous reactions to continuous glucose monitoring and continuous subcutaneous insulin infusion devices in type 1 diabetes mellitus. J Diabetes Sci Technol 15(4):786\u2013791","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"5568_CR84","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1089\/dia.2019.0159","volume":"22","author":"D Deiss","year":"2020","unstructured":"Deiss D, Irace C, Carlson G, Tweden KS, Kaufman FR (2020) Real-world safety of an implantable continuous glucose sensor over multiple cycles of use: a post-market registry study. Diabetes Technol Ther 22(1):48\u201352. https:\/\/doi.org\/10.1089\/dia.2019.0159","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"5568_CR85","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1089\/dia.2019.0234","volume":"21","author":"P Sanchez","year":"2019","unstructured":"Sanchez P, Ghosh-Dastidar S, Tweden KS, Kaufman FR (2019) Real-world data from the first U.S. commercial users of an implantable continuous glucose sensor. Diabetes Technol Ther 21(12):677\u2013681. https:\/\/doi.org\/10.1089\/dia.2019.0234","journal-title":"Diabetes Technol Ther"},{"key":"5568_CR86","unstructured":"National Institute for Health and Care Excellence (2021) Type 1 diabetes in adults: diagnosis and management. Available from: www.nice.org.uk\/guidance\/ng17. Accessed 10 June 2021"},{"issue":"10","key":"5568_CR87","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1111\/dom.14109","volume":"22","author":"T Danne","year":"2020","unstructured":"Danne T, Matsuhisa M, Sussebach C et al (2020) Lower risk of severe hypoglycaemia with insulin glargine 300\u2009U\/mL versus glargine 100\u2009U\/mL in participants with type 1 diabetes: a meta-analysis of 6-month phase 3 clinical trials. Diabetes Obes Metab 22(10):1880\u20131885. https:\/\/doi.org\/10.1111\/dom.14109","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"5568_CR88","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/jama.2017.7115","volume":"318","author":"W Lane","year":"2017","unstructured":"Lane W, Bailey TS, Gerety G et al (2017) Effect of insulin degludec vs insulin glargine U100 on hypoglycemia in patients with type 1 diabetes: the SWITCH 1 randomized clinical trial. JAMA 318(1):33\u201344. https:\/\/doi.org\/10.1001\/jama.2017.7115","journal-title":"JAMA."},{"issue":"1","key":"5568_CR89","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2337\/dc19-0888","volume":"43","author":"J \u0160oupal","year":"2020","unstructured":"\u0160oupal J, Petru\u017eelkov\u00e1 L, Grunberger G et al (2020) Glycemic outcomes in adults with T1D are impacted more by continuous glucose monitoring than by insulin delivery method: 3 years of follow-up from the COMISAIR study. Diabetes Care 43(1):37\u201343","journal-title":"Diabetes Care"},{"issue":"13","key":"5568_CR90","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1001\/jama.2016.11708","volume":"316","author":"RM Bergenstal","year":"2016","unstructured":"Bergenstal RM, Garg S, Weinzimer SA, Buckingham BA, Bode BW, Tamborlane WV et al (2016) Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA 316(13):1407\u20131408. https:\/\/doi.org\/10.1001\/jama.2016.11708","journal-title":"JAMA."},{"issue":"18","key":"5568_CR91","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1056\/NEJMoa1907863","volume":"381","author":"SA Brown","year":"2019","unstructured":"Brown SA, Kovatchev BP, Raghinaru D et al (2019) Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Engl J Med 381(18):1707\u20131717. https:\/\/doi.org\/10.1056\/NEJMoa1907863","journal-title":"N Engl J Med"},{"issue":"6","key":"5568_CR92","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1185\/03007995.2010.481203","volume":"26","author":"MA Gibney","year":"2010","unstructured":"Gibney MA, Arce CH, Byron KJ, Hirsch LJ (2010) Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin 26(6):1519\u20131530. https:\/\/doi.org\/10.1185\/03007995.2010.481203","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"5568_CR93","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s13300-020-00823-z","volume":"11","author":"J Kesavadev","year":"2020","unstructured":"Kesavadev J, Srinivasan S, Saboo B, Krishna BM, Krishnan G (2020) The do-it-yourself artificial pancreas: a comprehensive review. Diabetes Ther 11(6):1217\u20131235. https:\/\/doi.org\/10.1007\/s13300-020-00823-z","journal-title":"Diabetes Ther"},{"issue":"4","key":"5568_CR94","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/MOT.0000000000000786","volume":"25","author":"CK Boughton","year":"2020","unstructured":"Boughton CK, Hovorka R (2020) The artificial pancreas. Curr Opin Organ Transplant 25(4):336\u2013342. https:\/\/doi.org\/10.1097\/MOT.0000000000000786","journal-title":"Curr Opin Organ Transplant"},{"issue":"9","key":"5568_CR95","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.2337\/dc16-0610","volume":"39","author":"S Famulla","year":"2016","unstructured":"Famulla S, H\u00f6velmann U, Fischer A et al (2016) Insulin injection into lipohypertrophic tissue: blunted and more variable insulin absorption and action and impaired postprandial glucose control. Diabetes Care 39(9):1486\u20131492. https:\/\/doi.org\/10.2337\/dc16-0610","journal-title":"Diabetes Care"},{"issue":"5","key":"5568_CR96","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.diabet.2013.05.006","volume":"39","author":"M Blanco","year":"2013","unstructured":"Blanco M, Hern\u00e1ndez MT, Strauss KW, Amaya M (2013) Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab 39(5):445\u2013453. https:\/\/doi.org\/10.1016\/j.diabet.2013.05.006","journal-title":"Diabetes Metab"},{"issue":"10","key":"5568_CR97","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s40261-020-00958-8","volume":"40","author":"JB McGill","year":"2020","unstructured":"McGill JB, Peters A, Buse JB et al (2020) Comprehensive pulmonary safety review of inhaled Technosphere\u00ae insulin in patients with diabetes mellitus. Clin Drug Investig 40(10):973\u2013983. https:\/\/doi.org\/10.1007\/s40261-020-00958-8","journal-title":"Clin Drug Investig"},{"issue":"3","key":"5568_CR98","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00592-014-0557-3","volume":"51","author":"N Spaan","year":"2014","unstructured":"Spaan N, Teplova A, Stam G, Spaan J, Lucas C (2014) Systematic review: continuous intraperitoneal insulin infusion with implantable insulin pumps for diabetes mellitus. Acta Diabetol 51(3):339\u2013351. https:\/\/doi.org\/10.1007\/s00592-014-0557-3","journal-title":"Acta Diabetol"},{"issue":"2","key":"5568_CR99","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.diabet.2006.10.004","volume":"33","author":"E Renard","year":"2007","unstructured":"Renard E, Schaepelynck-B\u00e9licar P (2007) Implantable insulin pumps. A position statement about their clinical use. Diabetes Metab 33(2):158\u2013166. https:\/\/doi.org\/10.1016\/j.diabet.2006.10.004","journal-title":"Diabetes Metab"},{"key":"5568_CR100","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-016-4146-6","volume":"60","author":"The International Hypoglycaemia Study Group","year":"2017","unstructured":"The International Hypoglycaemia Study Group (2017) Glucose concentrations of less than 3.0 mmol\/L (54 mg\/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 60:3\u20136. https:\/\/doi.org\/10.1007\/s00125-016-4146-6","journal-title":"Diabetologia"},{"issue":"10128","key":"5568_CR101","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/S0140-6736(18)30297-6","volume":"391","author":"L Heinemann","year":"2018","unstructured":"Heinemann L, Freckmann G, Ehrmann D et al (2018) Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. Lancet. 391(10128):1367\u20131377. https:\/\/doi.org\/10.1016\/S0140-6736(18)30297-6","journal-title":"Lancet."},{"key":"5568_CR102","doi-asserted-by":"publisher","unstructured":"Renard E, Ikegami H, Daher Vianna AG et al (2020) The SAGE study: global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM. Diabetes Metab Res Rev. https:\/\/doi.org\/10.1002\/dmrr.3430","DOI":"10.1002\/dmrr.3430"},{"key":"5568_CR103","doi-asserted-by":"publisher","unstructured":"Seaquist ER, Anderson J, Childs B et al (2013) Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 36(5):1384\u20131395. https:\/\/doi.org\/10.2337\/dc12-2480","DOI":"10.2337\/dc12-2480"},{"issue":"4","key":"5568_CR104","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1056\/NEJMra1215228","volume":"369","author":"PE Cryer","year":"2013","unstructured":"Cryer PE (2013) Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 369(4):362\u2013372. https:\/\/doi.org\/10.1056\/NEJMra1215228","journal-title":"N Engl J Med"},{"issue":"6","key":"5568_CR105","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1210\/jc.2018-00142","volume":"103","author":"MM Henriksen","year":"2018","unstructured":"Henriksen MM, Andersen HU, Thorsteinsson B, Pedersen-Bjergaard U (2018) Hypoglycemic exposure and risk of asymptomatic hypoglycemia in type 1 diabetes assessed by continuous glucose monitoring. J Clin Endocrinol Metab 103(6):2329\u20132335. https:\/\/doi.org\/10.1210\/jc.2018-00142","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"5568_CR106","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jdiacomp.2017.09.005","volume":"32","author":"CAJ van Beers","year":"2018","unstructured":"van Beers CAJ, Caris MG, DeVries JH, Sern\u00e9 EH (2018) The relation between HbA1c and hypoglycemia revisited; a secondary analysis from an intervention trial in patients with type 1 diabetes and impaired awareness of hypoglycemia. J Diabetes Complicat 32(1):100\u2013103. https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.09.005","journal-title":"J Diabetes Complicat"},{"issue":"1","key":"5568_CR107","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/dme.13114","volume":"34","author":"V Gagnum","year":"2017","unstructured":"Gagnum V, Stene LC, Jenssen TG et al (2017) Causes of death in childhood-onset type 1 diabetes: long-term follow-up. Diabet Med 34(1):56\u201363. https:\/\/doi.org\/10.1111\/dme.13114","journal-title":"Diabet Med"},{"issue":"5","key":"5568_CR108","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S2213-8587(18)30315-2","volume":"7","author":"The International Hypoglycaemia Study Group","year":"2019","unstructured":"The International Hypoglycaemia Study Group (2019) Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol 7(5):385\u2013396. https:\/\/doi.org\/10.1016\/S2213-8587(18)30315-2","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"18","key":"5568_CR109","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1056\/NEJMoa066397","volume":"356","author":"The Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Study Research Group","year":"2007","unstructured":"The Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Study Research Group (2007) Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 356(18):1842\u20131852. https:\/\/doi.org\/10.1056\/NEJMoa066397","journal-title":"N Engl J Med"},{"issue":"7","key":"5568_CR110","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S2213-8587(21)00086-3","volume":"9","author":"AM Jacobson","year":"2021","unstructured":"Jacobson AM, Ryan CM, Braffett BH et al (2021) Cognitive performance declines in older adults with type 1 diabetes: results from 32 years of follow-up in the DCCT and EDIC study. Lancet Diabetes Endocrinol 9(7):436\u2013445. https:\/\/doi.org\/10.1016\/S2213-8587(21)00086-3","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"5568_CR111","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jdiacomp.2018.04.003","volume":"33","author":"NS Chaytor","year":"2019","unstructured":"Chaytor NS, Barbosa-Leiker C, Ryan CM, Germine LT, Hirsch IB, Weinstock RS (2019) Clinically significant cognitive impairment in older adults with type 1 diabetes. J Diabetes Complicat 33(1):91\u201397. https:\/\/doi.org\/10.1016\/j.jdiacomp.2018.04.003","journal-title":"J Diabetes Complicat"},{"issue":"6","key":"5568_CR112","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1111\/jdi.13290","volume":"11","author":"YK Lin","year":"2020","unstructured":"Lin YK, Fisher SJ, Pop-Busui R (2020) Hypoglycemia unawareness and autonomic dysfunction in diabetes: lessons learned and roles of diabetes technologies. J Diabetes Investig 11(6):1388\u20131402. https:\/\/doi.org\/10.1111\/jdi.13290","journal-title":"J Diabetes Investig"},{"issue":"4","key":"5568_CR113","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1464-5491.2008.02413.x","volume":"25","author":"J Geddes","year":"2008","unstructured":"Geddes J, Schopman JE, Zammitt NN, Frier BM (2008) Prevalence of impaired awareness of hypoglycaemia in adults with type 1 diabetes. Diabet Med 25(4):501\u2013504. https:\/\/doi.org\/10.1111\/j.1464-5491.2008.02413.x","journal-title":"Diabet Med"},{"issue":"7","key":"5568_CR114","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2337\/diacare.17.7.697","volume":"17","author":"AE Gold","year":"1994","unstructured":"Gold AE, MacLeod KM, Frier BM (1994) Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care 17(7):697\u2013703. https:\/\/doi.org\/10.2337\/diacare.17.7.697","journal-title":"Diabetes Care"},{"issue":"1 Pt 1","key":"5568_CR115","first-page":"E67","volume":"260","author":"A Mitrakou","year":"1991","unstructured":"Mitrakou A, Ryan C, Veneman T et al (1991) Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Phys 260(1 Pt 1):E67\u2013E74","journal-title":"Am J Phys"},{"issue":"4","key":"5568_CR116","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2337\/diacare.23.4.529","volume":"23","author":"MM Janssen","year":"2000","unstructured":"Janssen MM, Snoek FJ, Heine RJ (2000) Assessing impaired hypoglycemia awareness in type 1 diabetes: agreement of self-report but not of field study data with the autonomic symptom threshold during experimental hypoglycemia. Diabetes Care 23(4):529\u2013532. https:\/\/doi.org\/10.2337\/diacare.23.4.529","journal-title":"Diabetes Care"},{"issue":"4","key":"5568_CR117","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2337\/diacare.18.4.517","volume":"18","author":"WL Clarke","year":"1995","unstructured":"Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W (1995) Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 18(4):517\u2013522. https:\/\/doi.org\/10.2337\/diacare.18.4.517","journal-title":"Diabetes Care"},{"issue":"3","key":"5568_CR118","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/dmrr.377","volume":"19","author":"U Pedersen-Bjergaard","year":"2003","unstructured":"Pedersen-Bjergaard U, Pramming S, Thorsteinsson B (2003) Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes. Diabetes Metab Res Rev 19(3):232\u2013240. https:\/\/doi.org\/10.1002\/dmrr.377","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"5568_CR119","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/dme.12824","volume":"33","author":"J Speight","year":"2016","unstructured":"Speight J, Barendse SM, Singh H et al (2016) Characterizing problematic hypoglycaemia: iterative design and preliminary psychometric validation of the Hypoglycaemia Awareness Questionnaire (HypoA-Q). Diabet Med 33(3):376\u2013385. https:\/\/doi.org\/10.1111\/dme.12824","journal-title":"Diabet Med"},{"issue":"8","key":"5568_CR120","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.2337\/dc11-1579","volume":"35","author":"D Hopkins","year":"2012","unstructured":"Hopkins D, Lawrence I, Mansell P et al (2012) Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the U.K. DAFNE experience. Diabetes Care 35(8):1638\u20131642. https:\/\/doi.org\/10.2337\/dc11-1579","journal-title":"Diabetes Care"},{"issue":"3","key":"5568_CR121","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/dmrr.2492","volume":"30","author":"SA Little","year":"2014","unstructured":"Little SA, Leelarathna L, Barendse SM et al (2014) Severe hypoglycaemia in type 1 diabetes mellitus: underlying drivers and potential strategies for successful prevention. Diabetes Metab Res Rev 30(3):175\u2013190. https:\/\/doi.org\/10.1002\/dmrr.2492","journal-title":"Diabetes Metab Res Rev"},{"issue":"8","key":"5568_CR122","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.2337\/dc17-2682","volume":"41","author":"SA Little","year":"2018","unstructured":"Little SA, Speight J, Leelarathna L et al (2018) Sustained reduction in severe hypoglycemia in adults with type 1 diabetes complicated by impaired awareness of hypoglycemia: two-year follow-up in the HypoCOMPaSS randomized clinical trial. Diabetes Care 41(8):1600\u20131607. https:\/\/doi.org\/10.2337\/dc17-2682","journal-title":"Diabetes Care"},{"issue":"4","key":"5568_CR123","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00125-017-4334-z","volume":"61","author":"A Iqbal","year":"2018","unstructured":"Iqbal A, Heller SR (2018) The role of structured education in the management of hypoglycaemia. Diabetologia. 61(4):751\u2013760. https:\/\/doi.org\/10.1007\/s00125-017-4334-z","journal-title":"Diabetologia."},{"issue":"8918","key":"5568_CR124","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(94)91336-6","volume":"344","author":"I Cranston","year":"1994","unstructured":"Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA (1994) Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet. 344(8918):283\u2013287. https:\/\/doi.org\/10.1016\/S0140-6736(94)91336-6","journal-title":"Lancet."},{"issue":"8","key":"5568_CR125","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.2337\/dc15-0102","volume":"38","author":"E Yeoh","year":"2015","unstructured":"Yeoh E, Choudhary P, Nwokolo M, Ayis S, Amiel SA (2015) Interventions that restore awareness of hypoglycemia in adults with type 1 diabetes: a systematic review and meta-analysis. Diabetes Care 38(8):1592\u20131609. https:\/\/doi.org\/10.2337\/dc15-0102","journal-title":"Diabetes Care"},{"issue":"1","key":"5568_CR126","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2337\/diaspect.19.1.43","volume":"19","author":"DJ Cox","year":"2006","unstructured":"Cox DJ, Gonder-Frederick L, Ritterband L et al (2006) Blood glucose awareness training: what is it, where is it, and where is it going? Diabetes Spectrum 19(1):43\u201349. https:\/\/doi.org\/10.2337\/diaspect.19.1.43","journal-title":"Diabetes Spectrum"},{"issue":"12","key":"5568_CR127","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.2337\/dc16-1614","volume":"39","author":"SMPA Rondags","year":"2016","unstructured":"Rondags SMPA, de Wit M, Twisk JW, Snoek FJ (2016) Effectiveness of HypoAware, a brief partly web-based psychoeducational intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycemia: a cluster randomized controlled trial. Diabetes Care 39(12):2190\u20132196. https:\/\/doi.org\/10.2337\/dc16-1614","journal-title":"Diabetes Care"},{"issue":"3","key":"5568_CR128","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.2337\/dc09-1656","volume":"33","author":"N Hermanns","year":"2010","unstructured":"Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T (2010) Long-term effect of an education program (HyPOS) on the incidence of severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 33(3):e36\u2013e36. https:\/\/doi.org\/10.2337\/dc09-1656","journal-title":"Diabetes Care"},{"issue":"3","key":"5568_CR129","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ecl.2010.05.003","volume":"39","author":"PE Cryer","year":"2010","unstructured":"Cryer PE (2010) Hypoglycemia in type 1 diabetes mellitus. Endocrinol Metab Clin N Am 39(3):641\u2013654. https:\/\/doi.org\/10.1016\/j.ecl.2010.05.003","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"7","key":"5568_CR130","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1089\/dia.2020.0619","volume":"23","author":"JE Pinsker","year":"2021","unstructured":"Pinsker JE, Bartee A, Katz M et al (2021) Predictive low-glucose suspend necessitates less carbohydrate supplementation to rescue hypoglycemia: need to revisit current hypoglycemia treatment guidelines. Diabetes Technol Ther 23(7):512\u2013516. https:\/\/doi.org\/10.1089\/dia.2020.0619","journal-title":"Diabetes Technol Ther"},{"issue":"Suppl 1","key":"5568_CR131","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.2337\/dc19-S005","volume":"42","author":"American Diabetes Association","year":"2019","unstructured":"American Diabetes Association (2019) 5. Lifestyle management: standards of medical care in diabetes\u20142019. Diabetes Care 42(Suppl 1):S46\u2013S60. https:\/\/doi.org\/10.2337\/dc19-S005","journal-title":"Diabetes Care"},{"issue":"2","key":"5568_CR132","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S2213-8587(13)70144-X","volume":"2","author":"KJ Bell","year":"2014","unstructured":"Bell KJ, Barclay AW, Petocz P, Colagiuri S, Brand-Miller JC (2014) Efficacy of carbohydrate counting in type 1 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2(2):133\u2013140. https:\/\/doi.org\/10.1016\/S2213-8587(13)70144-X","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"5568_CR133","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/dme.12446","volume":"31","author":"S Schmidt","year":"2014","unstructured":"Schmidt S, Schelde B, N\u00f8rgaard K (2014) Effects of advanced carbohydrate counting in patients with type 1 diabetes: a systematic review. Diabet Med 31(8):886\u2013896. https:\/\/doi.org\/10.1111\/dme.12446","journal-title":"Diabet Med"},{"issue":"5","key":"5568_CR134","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2337\/dci19-0014","volume":"42","author":"AB Evert","year":"2019","unstructured":"Evert AB, Dennison M, Gardner CD et al (2019) Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care 42(5):731\u2013754. https:\/\/doi.org\/10.2337\/dci19-0014","journal-title":"Diabetes Care"},{"issue":"8","key":"5568_CR135","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/pedi.12496","volume":"18","author":"JM Hermann","year":"2017","unstructured":"Hermann JM, Meusers M, Bachran R et al (2017) Self-reported regular alcohol consumption in adolescents and emerging adults with type 1 diabetes: a neglected risk factor for diabetic ketoacidosis? Multicenter analysis of 29 630 patients from the DPV registry. Pediatr Diabetes 18(8):817\u2013823. https:\/\/doi.org\/10.1111\/pedi.12496","journal-title":"Pediatr Diabetes"},{"issue":"3","key":"5568_CR136","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/qjmed\/hcn163","volume":"102","author":"D Kerr","year":"2009","unstructured":"Kerr D, Penfold S, Zouwail S, Thomas P, Begley J (2009) The influence of liberal alcohol consumption on glucose metabolism in patients with type 1 diabetes: a pilot study. QJM 102(3):169\u2013174. https:\/\/doi.org\/10.1093\/qjmed\/hcn163","journal-title":"QJM."},{"issue":"11","key":"5568_CR137","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.2337\/diacare.24.11.1888","volume":"24","author":"BC Turner","year":"2001","unstructured":"Turner BC, Jenkins E, Kerr D, Sherwin RS, Cavan DA (2001) The effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes. Diabetes Care 24(11):1888\u20131893. https:\/\/doi.org\/10.2337\/diacare.24.11.1888","journal-title":"Diabetes Care"},{"issue":"3","key":"5568_CR138","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S2213-8587(19)30410-3","volume":"8","author":"A Pastor","year":"2020","unstructured":"Pastor A, Conn J, MacIsaac RJ, Bonomo Y (2020) Alcohol and illicit drug use in people with diabetes. Lancet Diabetes Endocrinol 8(3):239\u2013248. https:\/\/doi.org\/10.1016\/S2213-8587(19)30410-3","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"5568_CR139","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1464-5491.2012.03579.x","volume":"29","author":"K Barnard","year":"2012","unstructured":"Barnard K, Sinclair JMA, Lawton J, Young AJ, Holt RIG (2012) Alcohol-associated risks for young adults with type 1 diabetes: a narrative review. Diabet Med 29(4):434\u2013440. https:\/\/doi.org\/10.1111\/j.1464-5491.2012.03579.x","journal-title":"Diabet Med"},{"issue":"12","key":"5568_CR140","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1111\/dme.12491","volume":"31","author":"KD Barnard","year":"2014","unstructured":"Barnard KD, Dyson P, Sinclair JMA et al (2014) Alcohol health literacy in young adults with type 1 diabetes and its impact on diabetes management. Diabet Med 31(12):1625\u20131630. https:\/\/doi.org\/10.1111\/dme.12491","journal-title":"Diabet Med"},{"issue":"2","key":"5568_CR141","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00592-010-0200-x","volume":"50","author":"PA Engler","year":"2013","unstructured":"Engler PA, Ramsey SE, Smith RJ (2013) Alcohol use of diabetes patients: the need for assessment and intervention. Acta Diabetol 50(2):93\u201399. https:\/\/doi.org\/10.1007\/s00592-010-0200-x","journal-title":"Acta Diabetol"},{"issue":"19","key":"5568_CR142","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.115.017926","volume":"132","author":"A Pan","year":"2015","unstructured":"Pan A, Wang Y, Talaei M, Hu FB (2015) Relation of smoking with total mortality and cardiovascular events among patients with diabetes mellitus: a meta-analysis and systematic review. Circulation. 132(19):1795\u20131804. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.017926","journal-title":"Circulation."},{"key":"5568_CR143","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.mvr.2014.01.002","volume":"92","author":"A Uruska","year":"2014","unstructured":"Uruska A, Araszkiewicz A, Uruski P, Zozulinska-Ziolkiewicz D (2014) Higher risk of microvascular complications in smokers with type 1 diabetes despite intensive insulin therapy. Microvasc Res 92:79\u201384. https:\/\/doi.org\/10.1016\/j.mvr.2014.01.002","journal-title":"Microvasc Res"},{"issue":"12","key":"5568_CR144","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.2337\/dc17-0615","volume":"40","author":"H Tikkanen-Dolenc","year":"2017","unstructured":"Tikkanen-Dolenc H, Wad\u00e9n J, Forsblom C et al (2017) Physical activity reduces risk of premature mortality in patients with type 1 diabetes with and without kidney disease. Diabetes Care 40(12):1727\u20131732. https:\/\/doi.org\/10.2337\/dc17-0615","journal-title":"Diabetes Care"},{"issue":"8","key":"5568_CR145","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.2337\/dc15-0030","volume":"38","author":"B Bohn","year":"2015","unstructured":"Bohn B, Herbst A, Pfeifer M et al (2015) Impact of physical activity on glycemic control and prevalence of cardiovascular risk factors in adults with type 1 diabetes: a cross-sectional multicenter study of 18,028 patients. Diabetes Care 38(8):1536\u20131543. https:\/\/doi.org\/10.2337\/dc15-0030","journal-title":"Diabetes Care"},{"issue":"2","key":"5568_CR146","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/jcm8020253","volume":"8","author":"N Wu","year":"2019","unstructured":"Wu N, Bredin SSD, Guan Y et al (2019) Cardiovascular health benefits of exercise training in persons living with type 1 diabetes: a systematic review and meta-analysis. J Clin Med 8(2):253. https:\/\/doi.org\/10.3390\/jcm8020253","journal-title":"J Clin Med"},{"issue":"3","key":"5568_CR147","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s00125-011-2403-2","volume":"55","author":"M Chimen","year":"2012","unstructured":"Chimen M, Kennedy A, Nirantharakumar K, Pang TT, Andrews R, Narendran P (2012) What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review. Diabetologia. 55(3):542\u2013551. https:\/\/doi.org\/10.1007\/s00125-011-2403-2","journal-title":"Diabetologia."},{"issue":"2","key":"5568_CR148","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2337\/dc07-1238","volume":"31","author":"J Wad\u00e9n","year":"2008","unstructured":"Wad\u00e9n J, Forsblom C, Thorn LM et al (2008) Physical activity and diabetes complications in patients with type 1 diabetes: the Finnish Diabetic Nephropathy (FinnDiane) Study. Diabetes Care 31(2):230\u2013232. https:\/\/doi.org\/10.2337\/dc07-1238","journal-title":"Diabetes Care"},{"issue":"12","key":"5568_CR149","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1007\/s00125-020-05263-9","volume":"63","author":"O Moser","year":"2020","unstructured":"Moser O, Riddell MC, Eckstein ML et al (2020) Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA). Diabetologia. 63(12):2501\u20132520","journal-title":"Diabetologia."},{"issue":"7","key":"5568_CR150","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1249\/01.MSS.0000074459.41029.75","volume":"35","author":"JW Lemaster","year":"2003","unstructured":"Lemaster JW, Reiber GE, Smith DG, Heagerty PJ, Wallace C (2003) Daily weight-bearing activity does not increase the risk of diabetic foot ulcers. Med Sci Sports Exerc 35(7):1093\u20131099. https:\/\/doi.org\/10.1249\/01.MSS.0000074459.41029.75","journal-title":"Med Sci Sports Exerc"},{"issue":"5","key":"5568_CR151","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S2213-8587(17)30014-1","volume":"5","author":"MC Riddell","year":"2017","unstructured":"Riddell MC, Gallen IW, Smart CE et al (2017) Exercise management in type 1 diabetes: a consensus statement. Lancet Diabetes Endocrinol 5(5):377\u2013390. https:\/\/doi.org\/10.1016\/S2213-8587(17)30014-1","journal-title":"Lancet Diabetes Endocrinol"},{"key":"5568_CR152","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2337\/9781580404853","volume-title":"Exercise and diabetes: a clinician\u2019s guide to prescribing physical activity","author":"SR Colberg","year":"2013","unstructured":"Colberg SR (2013) Older Adults. In: Colberg SR (ed) Exercise and diabetes: a clinician\u2019s guide to prescribing physical activity, 1st edn. American Diabetes Association, Alexandria, VA, pp 424","edition":"1"},{"key":"5568_CR153","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.sleep.2016.03.019","volume":"23","author":"S Reutrakul","year":"2016","unstructured":"Reutrakul S, Thakkinstian A, Anothaisintawee T, Chontong S, Borel A-L, Perfect MM et al (2016) Sleep characteristics in type 1 diabetes and associations with glycemic control: systematic review and meta-analysis. Sleep Med 23:26\u201345. https:\/\/doi.org\/10.1016\/j.sleep.2016.03.019","journal-title":"Sleep Med"},{"key":"5568_CR154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabres.2016.06.013","volume":"119","author":"H Denic-Roberts","year":"2016","unstructured":"Denic-Roberts H, Costacou T, Orchard TJ (2016) Subjective sleep disturbances and glycemic control in adults with long-standing type 1 diabetes: the Pittsburgh\u2019s Epidemiology of Diabetes Complications study. Diabetes Res Clin Pract 119:1\u201312. https:\/\/doi.org\/10.1016\/j.diabres.2016.06.013","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"5568_CR155","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s00125-011-2184-7","volume":"54","author":"M van Dijk","year":"2011","unstructured":"van Dijk M, Donga E, van Dijk JG et al (2011) Disturbed subjective sleep characteristics in adult patients with long-standing type 1 diabetes mellitus. Diabetologia. 54(8):1967\u20131976. https:\/\/doi.org\/10.1007\/s00125-011-2184-7","journal-title":"Diabetologia."},{"issue":"Suppl 1","key":"5568_CR156","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.2337\/dc20-S006","volume":"43","author":"American Diabetes Association","year":"2020","unstructured":"American Diabetes Association (2020) 6. Glycemic targets: standards of medical care in diabetes-2020. Diabetes Care 43(Suppl 1):S66\u2013S76. https:\/\/doi.org\/10.2337\/dc20-S006","journal-title":"Diabetes Care"},{"key":"5568_CR157","unstructured":"Centers for Disease Control and Prevention (2020) Managing sick days. Available from: www.cdc.gov\/diabetes\/managing\/flu-sick-days.html. Accessed 16 July 2021"},{"key":"5568_CR158","unstructured":"Diabetes UK (2021) Diabetes when you\u2019re unwell. Available from: www.diabetes.org.uk\/guide-to-diabetes\/life-with-diabetes\/illness. Accessed 16 July 2021"},{"key":"5568_CR159","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40842-015-0007-3","volume":"1","author":"AJ Graveling","year":"2015","unstructured":"Graveling AJ, Frier BM (2015) Driving and diabetes: problems, licensing restrictions and recommendations for safe driving. Clin Diabetes Endocrinol 1:8","journal-title":"Clin Diabetes Endocrinol"},{"key":"5568_CR160","doi-asserted-by":"publisher","unstructured":"American Diabetes Association (2014) Diabetes and driving. Diabetes Care 37(Supp 1):S97\u2013S103. https:\/\/doi.org\/10.2337\/dc14-S097","DOI":"10.2337\/dc14-S097"},{"issue":"Suppl 1","key":"5568_CR161","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.2337\/dc14-S112","volume":"37","author":"American Diabetes Association","year":"2014","unstructured":"American Diabetes Association (2014) Diabetes and employment. Diabetes Care 37(Suppl 1):S112\u2013S117","journal-title":"Diabetes Care"},{"key":"5568_CR162","unstructured":"Sansum Diabetes Research Institute (2019) Time zones. Available from: https:\/\/diabetestravel.sansum.org\/time-zones\/. Accessed 19 February 2021"},{"issue":"2","key":"5568_CR163","doi-asserted-by":"publisher","first-page":"141","DOI":"10.15277\/bjd.2019.224","volume":"19","author":"AR Charlton","year":"2019","unstructured":"Charlton AR, Charlton JR (2019) World travel with type 1 diabetes using continuous subcutaneous insulin infusion. Br J Diabetes 19(2):141\u2013146. https:\/\/doi.org\/10.15277\/bjd.2019.224","journal-title":"Br J Diabetes"},{"key":"5568_CR164","unstructured":"IDF and the Diabetes & Ramadan International Alliance. Diabetes and Ramadan: Practical Guidelines 2021 (2021). Available from: https:\/\/idf.org\/e-library\/guidelines\/165-idf-dar-practical-guidelines-2021.html. Accessed 16 July 2021"},{"issue":"7","key":"5568_CR165","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1037\/a0040408","volume":"71","author":"M de Groot","year":"2016","unstructured":"de Groot M, Golden SH, Wagner J (2016) Psychological conditions in adults with diabetes. Am Psychol 71(7):552\u2013562. https:\/\/doi.org\/10.1037\/a0040408","journal-title":"Am Psychol"},{"issue":"4","key":"5568_CR166","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/dme.14216","volume":"37","author":"E van Duinkerken","year":"2020","unstructured":"van Duinkerken E, Snoek FJ, de Wit M (2020) The cognitive and psychological effects of living with type 1 diabetes: a narrative review. Diabet Med 37(4):555\u2013563. https:\/\/doi.org\/10.1111\/dme.14216","journal-title":"Diabet Med"},{"issue":"8","key":"5568_CR167","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/dme.14165","volume":"37","author":"J Speight","year":"2020","unstructured":"Speight J, Hendrieckx C, Pouwer F, Skinner TC, Snoek FJ (2020) Back to the future: 25 years of \u201cGuidelines for encouraging psychological well-being\u201d among people affected by diabetes. Diabet Med 37(8):1225\u20131229. https:\/\/doi.org\/10.1111\/dme.14165","journal-title":"Diabet Med"},{"issue":"4","key":"5568_CR168","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jdiacomp.2015.01.012","volume":"29","author":"L Fisher","year":"2015","unstructured":"Fisher L, Polonsky WH, Hessler DM et al (2015) Understanding the sources of diabetes distress in adults with type 1 diabetes. J Diabetes Complicat 29(4):572\u2013577. https:\/\/doi.org\/10.1016\/j.jdiacomp.2015.01.012","journal-title":"J Diabetes Complicat"},{"issue":"9","key":"5568_CR169","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/dme.13381","volume":"34","author":"DM Hessler","year":"2017","unstructured":"Hessler DM, Fisher L, Polonsky WH et al (2017) Diabetes distress is linked with worsening diabetes management over time in adults with type 1 diabetes. Diabet Med 34(9):1228\u20131234. https:\/\/doi.org\/10.1111\/dme.13381","journal-title":"Diabet Med"},{"issue":"3","key":"5568_CR170","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/dme.14226","volume":"37","author":"M de Wit","year":"2020","unstructured":"de Wit M, Trief PM, Huber JW, Willaing I (2020) State of the art: understanding and integration of the social context in diabetes care. Diabet Med 37(3):473\u2013482. https:\/\/doi.org\/10.1111\/dme.14226","journal-title":"Diabet Med"},{"issue":"4","key":"5568_CR171","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1464-5491.2006.01814.x","volume":"23","author":"KD Barnard","year":"2006","unstructured":"Barnard KD, Skinner TC, Peveler R (2006) The prevalence of co-morbid depression in adults with type 1 diabetes: systematic literature review. Diabet Med 23(4):445\u2013448. https:\/\/doi.org\/10.1111\/j.1464-5491.2006.01814.x","journal-title":"Diabet Med"},{"issue":"3","key":"5568_CR172","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1464-5491.2005.01414.x","volume":"22","author":"N Hermanns","year":"2005","unstructured":"Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T (2005) Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors. Diabet Med 22(3):293\u2013300. https:\/\/doi.org\/10.1111\/j.1464-5491.2005.01414.x","journal-title":"Diabet Med"},{"issue":"2","key":"5568_CR173","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jpsychores.2012.11.013","volume":"74","author":"KJ Smith","year":"2013","unstructured":"Smith KJ, B\u00e9land M, Clyde M et al (2013) Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res 74(2):89\u201399. https:\/\/doi.org\/10.1016\/j.jpsychores.2012.11.013","journal-title":"J Psychosom Res"},{"issue":"6","key":"5568_CR174","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S2213-8587(15)00135-7","volume":"3","author":"FJ Snoek","year":"2015","unstructured":"Snoek FJ, Bremmer MA, Hermanns N (2015) Constructs of depression and distress in diabetes: time for an appraisal. Lancet Diabetes Endocrinol 3(6):450\u2013460. https:\/\/doi.org\/10.1016\/S2213-8587(15)00135-7","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"5568_CR175","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/dme.14227","volume":"37","author":"F Pouwer","year":"2020","unstructured":"Pouwer F, Schram MT, Iversen MM, Nouwen A, Holt RIG (2020) How 25 years of psychosocial research has contributed to a better understanding of the links between depression and diabetes. Diabet Med 37(3):383\u2013392. https:\/\/doi.org\/10.1111\/dme.14227","journal-title":"Diabet Med"},{"issue":"11","key":"5568_CR176","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1111\/dme.12973","volume":"33","author":"L Fisher","year":"2016","unstructured":"Fisher L, Hessler DM, Polonsky WH et al (2016) Prevalence of depression in type 1 diabetes and the problem of over-diagnosis. Diabet Med 33(11):1590\u20131597. https:\/\/doi.org\/10.1111\/dme.12973","journal-title":"Diabet Med"},{"issue":"1","key":"5568_CR177","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/14768320701205218","volume":"23","author":"S Sultan","year":"2008","unstructured":"Sultan S, Epel E, Sachon C, Vaillant G, Hartemann-Heurtier A (2008) A longitudinal study of coping, anxiety and glycemic control in adults with type 1 diabetes. Psychol Health 23(1):73\u201389","journal-title":"Psychol Health"},{"issue":"8","key":"5568_CR178","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jdiacomp.2019.04.013","volume":"33","author":"G Nefs","year":"2019","unstructured":"Nefs G, Hendrieckx C, Reddy P et al (2019) Comorbid elevated symptoms of anxiety and depression in adults with type 1 or type 2 diabetes: results from the International Diabetes MILES study. J Diabetes Complicat 33(8):523\u2013529. https:\/\/doi.org\/10.1016\/j.jdiacomp.2019.04.013","journal-title":"J Diabetes Complicat"},{"issue":"12","key":"5568_CR179","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1111\/dme.14286","volume":"37","author":"J Nano","year":"2020","unstructured":"Nano J, Carinci F, Okunade O et al (2020) A standard set of person-centred outcomes for diabetes mellitus: results of an international and unified approach. Diabet Med 37(12):2009\u20132018. https:\/\/doi.org\/10.1111\/dme.14286","journal-title":"Diabet Med"},{"key":"5568_CR180","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jad.2013.12.015","volume":"156","author":"T Krieger","year":"2014","unstructured":"Krieger T, Zimmermann J, Huffziger S et al (2014) Measuring depression with a well-being index: further evidence for the validity of the WHO Well-Being Index (WHO-5) as a measure of the severity of depression. J Affect Disord 156:240\u2013244. https:\/\/doi.org\/10.1016\/j.jad.2013.12.015","journal-title":"J Affect Disord"},{"issue":"6","key":"5568_CR181","doi-asserted-by":"publisher","first-page":"754","DOI":"10.2337\/diacare.18.6.754","volume":"18","author":"WH Polonsky","year":"1995","unstructured":"Polonsky WH, Anderson BJ, Lohrer PA et al (1995) Assessment of diabetes-related distress. Diabetes Care 18(6):754\u2013760. https:\/\/doi.org\/10.2337\/diacare.18.6.754","journal-title":"Diabetes Care"},{"issue":"9","key":"5568_CR182","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9):606\u2013613. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x","journal-title":"J Gen Intern Med"},{"issue":"10","key":"5568_CR183","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B (2006) A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 166(10):1092\u20131097. https:\/\/doi.org\/10.1001\/archinte.166.10.1092","journal-title":"Arch Intern Med"},{"issue":"11","key":"5568_CR184","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","volume":"41","author":"K Kroenke","year":"2003","unstructured":"Kroenke K, Spitzer RL, Williams JBW (2003) The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 41(11):1284\u20131292. https:\/\/doi.org\/10.1097\/01.MLR.0000093487.78664.3C","journal-title":"Med Care"},{"issue":"6","key":"5568_CR185","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1176\/appi.psy.50.6.613","volume":"50","author":"K Kroenke","year":"2009","unstructured":"Kroenke K, Spitzer RL, Williams JBW, L\u00f6we B (2009) An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 50(6):613\u2013621. https:\/\/doi.org\/10.1176\/appi.psy.50.6.613","journal-title":"Psychosomatics."},{"issue":"1","key":"5568_CR186","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00125-009-1559-5","volume":"53","author":"BE McGuire","year":"2010","unstructured":"McGuire BE, Morrison TG, Hermanns N et al (2010) Short-form measures of diabetes-related emotional distress: the Problem Areas in Diabetes Scale (PAID)-5 and PAID-1. Diabetologia. 53(1):66\u201369. https:\/\/doi.org\/10.1007\/s00125-009-1559-5","journal-title":"Diabetologia."},{"issue":"3","key":"5568_CR187","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1370\/afm.842","volume":"6","author":"L Fisher","year":"2008","unstructured":"Fisher L, Glasgow RE, Mullan JT, Skaff MM, Polonsky WH (2008) Development of a brief diabetes distress screening instrument. Ann Fam Med 6(3):246\u2013252. https:\/\/doi.org\/10.1370\/afm.842","journal-title":"Ann Fam Med"},{"issue":"11","key":"5568_CR188","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.2337\/diacare.24.11.1929","volume":"24","author":"F Pouwer","year":"2001","unstructured":"Pouwer F, Snoek FJ, van der Ploeg HM, Ad\u00e8r HJ, Heine RJ (2001) Monitoring of psychological well-being in outpatients with diabetes: effects on mood, HbA1c, and the patient\u2019s evaluation of the quality of diabetes care: a randomized controlled trial. Diabetes Care 24(11):1929\u20131935. https:\/\/doi.org\/10.2337\/diacare.24.11.1929","journal-title":"Diabetes Care"},{"issue":"11","key":"5568_CR189","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.2337\/dc11-1326","volume":"35","author":"FJ Snoek","year":"2012","unstructured":"Snoek FJ, Kersch NYA, Eldrup E et al (2012) Monitoring of Individual Needs in Diabetes (MIND)-2: follow-up data from the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) MIND study. Diabetes Care 35(11):2128\u20132132. https:\/\/doi.org\/10.2337\/dc11-1326","journal-title":"Diabetes Care"},{"issue":"1","key":"5568_CR190","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.pec.2007.05.003","volume":"68","author":"D Wild","year":"2007","unstructured":"Wild D, von Maltzahn R, Brohan E, Christensen T, Clauson P, Gonder-Frederick L (2007) A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ Couns 68(1):10\u201315. https:\/\/doi.org\/10.1016\/j.pec.2007.05.003","journal-title":"Patient Educ Couns"},{"key":"5568_CR191","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/9781118695432.ch16","volume-title":"Hypoglycaemia in clinical diabetes","author":"FJ Snoek","year":"2014","unstructured":"Snoek FJ, Hajos TRS, Rondags SMPA (2014) Psychological effects of hypoglycaemia. In: Frier BM, Heller SR, McCrimmon RJ (eds) Hypoglycaemia in clinical diabetes. John Wiley & Sons, Chichester, pp 323\u2013333"},{"issue":"4","key":"5568_CR192","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2337\/dc10-1343","volume":"34","author":"LA Gonder-Frederick","year":"2011","unstructured":"Gonder-Frederick LA, Schmidt KM, Vajda KA et al (2011) Psychometric properties of the hypoglycemia fear survey-ii for adults with type 1 diabetes. Diabetes Care 34(4):801\u2013806. https:\/\/doi.org\/10.2337\/dc10-1343","journal-title":"Diabetes Care"},{"key":"5568_CR193","doi-asserted-by":"publisher","unstructured":"Jones JM, Lawson ML, Daneman D, Olmsted MP, Rodin G (2000) Eating disorders in adolescent females with and without type 1 diabetes: cross sectional study. BMJ 320(7249):1563\u20131566. https:\/\/doi.org\/10.1136\/bmj.320.7249.1563","DOI":"10.1136\/bmj.320.7249.1563"},{"issue":"7","key":"5568_CR194","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.2337\/dc14-2646","volume":"38","author":"PA Colton","year":"2015","unstructured":"Colton PA, Olmsted MP, Daneman D et al (2015) Eating disorders in girls and women with type 1 diabetes: a longitudinal study of prevalence, onset, remission, and recurrence. Diabetes Care 38(7):1212\u20131217. https:\/\/doi.org\/10.2337\/dc14-2646","journal-title":"Diabetes Care"},{"issue":"9","key":"5568_CR195","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.2337\/dc19-0445","volume":"42","author":"K Luyckx","year":"2019","unstructured":"Luyckx K, Verschueren M, Palmeroni N, Goethals ER, Weets I, Claes L (2019) Disturbed eating behaviors in adolescents and emerging adults with type 1 diabetes: a one-year prospective study. Diabetes Care 42(9):1637\u20131644. https:\/\/doi.org\/10.2337\/dc19-0445","journal-title":"Diabetes Care"},{"key":"5568_CR196","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.appet.2017.03.035","volume":"114","author":"L Wisting","year":"2017","unstructured":"Wisting L, Reas DL, Bang L, Skrivarhaug T, Dahl-J\u00f8rgensen K, R\u00f8 \u00d8 (2017) Eating patterns in adolescents with type 1 diabetes: associations with metabolic control, insulin omission, and eating disorder pathology. Appetite. 114:226\u2013231. https:\/\/doi.org\/10.1016\/j.appet.2017.03.035","journal-title":"Appetite."},{"issue":"4","key":"5568_CR197","doi-asserted-by":"publisher","first-page":"E317","DOI":"10.1111\/jpc.12014","volume":"49","author":"H d\u2019Emden","year":"2013","unstructured":"d\u2019Emden H, Holden L, McDermott B et al (2013) Disturbed eating behaviours and thoughts in Australian adolescents with type 1 diabetes. J Paediatr Child Health 49(4):E317\u2013E323. https:\/\/doi.org\/10.1111\/jpc.12014","journal-title":"J Paediatr Child Health"},{"key":"5568_CR198","doi-asserted-by":"publisher","unstructured":"Hill-Briggs F, Adler NE, Berkowitz SA et al (2020) Social determinants of health and diabetes: a scientific review. Diabetes Care. https:\/\/doi.org\/10.2337\/dci20-0053","DOI":"10.2337\/dci20-0053"},{"key":"5568_CR199","unstructured":"Centers for Disease Control and Prevention (2021) Tools for Putting Social Determinants of Health into Action. Available from: www.cdc.gov\/socialdeterminants\/tools\/index.htm. Accessed 18 February 2021"},{"key":"5568_CR200","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7013.1000190","volume-title":"Capturing social and behavioral domains and measures in electronic health records: phase 2","author":"Institute of Medicine","year":"2014","unstructured":"Institute of Medicine (2014) Capturing social and behavioral domains and measures in electronic health records: phase 2. The National Academies Press, Washington, DC. https:\/\/doi.org\/10.4172\/2157-7013.1000190"},{"key":"5568_CR201","unstructured":"American Academy of Family Physicians (2018) Social Needs Screening Tool. Available from: www.aafp.org\/dam\/AAFP\/documents\/patient_care\/everyone_project\/hops19-physician-form-sdoh.pdf. Accessed 23 August 2021"},{"issue":"2","key":"5568_CR202","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.amepre.2016.07.033","volume":"52","author":"NB Giuse","year":"2017","unstructured":"Giuse NB, Koonce TY, Kusnoor SV et al (2017) Institute of medicine measures of social and behavioral determinants of health: a feasibility study. Am J Prev Med 52(2):199\u2013206. https:\/\/doi.org\/10.1016\/j.amepre.2016.07.033","journal-title":"Am J Prev Med"},{"issue":"4","key":"5568_CR203","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2337\/dc19-1586","volume":"43","author":"RJ Walker","year":"2020","unstructured":"Walker RJ, Garacci E, Palatnik A, Ozieh MN, Egede LE (2020) The longitudinal influence of social determinants of health on glycemic control in elderly adults with Diabetes. Diabetes Care 43(4):759\u2013766. https:\/\/doi.org\/10.2337\/dc19-1586","journal-title":"Diabetes Care"},{"issue":"4","key":"5568_CR204","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.amepre.2019.11.011","volume":"58","author":"CG Heller","year":"2020","unstructured":"Heller CG, Parsons AS, Chambers EC, Fiori KP, Rehm CD (2020) Social risks among primary care patients in a large urban health system. Am J Prev Med 58(4):514\u2013525. https:\/\/doi.org\/10.1016\/j.amepre.2019.11.011","journal-title":"Am J Prev Med"},{"issue":"12","key":"5568_CR205","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.2337\/dc16-2053","volume":"39","author":"D Young-Hyman","year":"2016","unstructured":"Young-Hyman D, de Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M (2016) Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care 39(12):2126\u20132140. https:\/\/doi.org\/10.2337\/dc16-2053","journal-title":"Diabetes Care"},{"issue":"4","key":"5568_CR206","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.genhosppsych.2010.03.011","volume":"32","author":"CM van der Feltz-Cornelis","year":"2010","unstructured":"van der Feltz-Cornelis CM, Nuyen J, Stoop C et al (2010) Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. Gen Hosp Psychiatry 32(4):380\u2013395. https:\/\/doi.org\/10.1016\/j.genhosppsych.2010.03.011","journal-title":"Gen Hosp Psychiatry"},{"issue":"6","key":"5568_CR207","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.eurpsy.2009.01.005","volume":"24","author":"M De Hert","year":"2009","unstructured":"De Hert M, Dekker JM, Wood D, Kahl KG, Holt RIG, M\u00f6ller H-J (2009) Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 24(6):412\u2013424. https:\/\/doi.org\/10.1016\/j.eurpsy.2009.01.005","journal-title":"Eur Psychiatry"},{"issue":"6","key":"5568_CR208","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jcjd.2020.02.006","volume":"44","author":"V Stenov","year":"2020","unstructured":"Stenov V, Joensen LE, Knudsen L, Lindqvist Hansen D, Willaing Tapager I (2020) \u201cMental health professionals have never mentioned my diabetes, they don\u2019t get into that\u201d: a qualitative study of support needs in adults with type 1 and type 2 diabetes and severe mental illness. Can J Diabetes 44(6):494\u2013500. https:\/\/doi.org\/10.1016\/j.jcjd.2020.02.006","journal-title":"Can J Diabetes"},{"issue":"5","key":"5568_CR209","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2337\/dc19-2449","volume":"43","author":"SR Benoit","year":"2020","unstructured":"Benoit SR, Hora I, Pasquel FJ, Gregg EW, Albright AL, Imperatore G (2020) Trends in emergency department visits and inpatient admissions for hyperglycemic crises in adults with diabetes in the U.S., 2006-2015. Diabetes Care 43(5):1057\u20131064. https:\/\/doi.org\/10.2337\/dc19-2449","journal-title":"Diabetes Care"},{"issue":"3","key":"5568_CR210","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.2337\/dc18-1160","volume":"42","author":"H Kalscheuer","year":"2019","unstructured":"Kalscheuer H, Seufert J, Lanzinger S et al (2019) Event rates and risk factors for the development of diabetic ketoacidosis in adult patients with type 1 diabetes: analysis from the DPV registry based on 46,966 patients. Diabetes Care 42(3):e34\u2013e36. https:\/\/doi.org\/10.2337\/dc18-1160","journal-title":"Diabetes Care"},{"issue":"5","key":"5568_CR211","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S2213-8587(20)30042-5","volume":"8","author":"D Ehrmann","year":"2020","unstructured":"Ehrmann D, Kulzer B, Roos T, Haak T, Al-Khatib M, Hermanns N (2020) Risk factors and prevention strategies for diabetic ketoacidosis in people with established type 1 diabetes. Lancet Diabetes Endocrinol 8(5):436\u2013446. https:\/\/doi.org\/10.1016\/S2213-8587(20)30042-5","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"5568_CR212","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2337\/dc19-0365","volume":"43","author":"GL Kinney","year":"2020","unstructured":"Kinney GL, Akturk HK, Taylor DD, Foster NC, Shah VN (2020) Cannabis use is associated with increased risk for diabetic ketoacidosis in adults with type 1 diabetes: findings from the T1D exchange clinic registry. Diabetes Care 43(1):247\u2013249","journal-title":"Diabetes Care"},{"key":"5568_CR213","doi-asserted-by":"publisher","unstructured":"Hare MJL, Deitch JM, Kang MJY, Bach LA (2020) Clinical, psychological and demographic factors in a contemporary adult cohort with diabetic ketoacidosis and type 1 diabetes. Intern Med J. https:\/\/doi.org\/10.1111\/imj.14877","DOI":"10.1111\/imj.14877"},{"issue":"1","key":"5568_CR214","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1089\/152091504322783350","volume":"6","author":"SK Garg","year":"2004","unstructured":"Garg SK, Walker AJ, Hoff HK, D\u2019Souza AO, Gottlieb PA, Chase HP (2004) Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump. Diabetes Technol Ther 6(1):9\u201315. https:\/\/doi.org\/10.1089\/152091504322783350","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"5568_CR215","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1089\/dia.2017.0231","volume":"20","author":"S Hoshina","year":"2018","unstructured":"Hoshina S, Andersen GS, J\u00f8rgensen ME, Ridderstr\u00e5le M, Vistisen D, Andersen HU (2018) Treatment modality-dependent risk of diabetic ketoacidosis in patients with type 1 diabetes: Danish Adult Diabetes Database Study. Diabetes Technol Ther 20(3):229\u2013234. https:\/\/doi.org\/10.1089\/dia.2017.0231","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"5568_CR216","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2337\/dc18-2316","volume":"42","author":"T Danne","year":"2019","unstructured":"Danne T, Garg S, Peters AL et al (2019) International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors. Diabetes Care 42(6):1147\u20131154. https:\/\/doi.org\/10.2337\/dc18-2316","journal-title":"Diabetes Care"},{"issue":"10","key":"5568_CR217","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1111\/dom.13811","volume":"21","author":"RM Goldenberg","year":"2019","unstructured":"Goldenberg RM, Gilbert JD, Hramiak IM, Woo VC, Zinman B (2019) Sodium-glucose co-transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: the STOP DKA protocol. Diabetes Obes Metab 21(10):2192\u20132202. https:\/\/doi.org\/10.1111\/dom.13811","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"5568_CR218","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.2337\/dc15-0843","volume":"38","author":"AL Peters","year":"2015","unstructured":"Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB (2015) Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care 38(9):1687\u20131693. https:\/\/doi.org\/10.2337\/dc15-0843","journal-title":"Diabetes Care"},{"issue":"5","key":"5568_CR219","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11892-017-0857-4","volume":"17","author":"KK Dhatariya","year":"2017","unstructured":"Dhatariya KK, Vellanki P (2017) Treatment of diabetic ketoacidosis (DKA)\/hyperglycemic hyperosmolar state (HHS): novel advances in the management of hyperglycemic crises (UK versus USA). Curr Diab Rep 17(5):33","journal-title":"Curr Diab Rep"},{"issue":"5","key":"5568_CR220","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1210\/jc.2007-2577","volume":"93","author":"AE Kitabchi","year":"2008","unstructured":"Kitabchi AE, Umpierrez GE, Fisher JN, Murphy MB, Stentz FB (2008) Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab 93(5):1541\u20131552. https:\/\/doi.org\/10.1210\/jc.2007-2577","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"5568_CR221","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1464-5491.2011.03246.x","volume":"28","author":"MW Savage","year":"2011","unstructured":"Savage MW, Dhatariya KK, Kilvert A et al (2011) Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis. Diabet Med 28(5):508\u2013515. https:\/\/doi.org\/10.1111\/j.1464-5491.2011.03246.x","journal-title":"Diabet Med"},{"issue":"4","key":"5568_CR222","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrendo.2016.15","volume":"12","author":"G Umpierrez","year":"2016","unstructured":"Umpierrez G, Korytkowski M (2016) Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol 12(4):222\u2013232. https:\/\/doi.org\/10.1038\/nrendo.2016.15","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"5568_CR223","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nrendo.2013.138","volume":"9","author":"RWG Gruessner","year":"2013","unstructured":"Gruessner RWG, Gruessner AC (2013) The current state of pancreas transplantation. Nat Rev Endocrinol 9(9):555\u2013562. https:\/\/doi.org\/10.1038\/nrendo.2013.138","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"5568_CR224","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.2337\/dc12-0063","volume":"35","author":"FB Barton","year":"2012","unstructured":"Barton FB, Rickels MR, Alejandro R et al (2012) Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care 35(7):1436\u20131445. https:\/\/doi.org\/10.2337\/dc12-0063","journal-title":"Diabetes Care"},{"issue":"6","key":"5568_CR225","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/TP.0000000000000288","volume":"98","author":"N Niclauss","year":"2014","unstructured":"Niclauss N, Morel P, Berney T (2014) Has the gap between pancreas and islet transplantation closed? Transplantation. 98(6):593\u2013599. https:\/\/doi.org\/10.1097\/TP.0000000000000288","journal-title":"Transplantation."},{"issue":"5","key":"5568_CR226","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s11892-011-0211-1","volume":"11","author":"R Bassi","year":"2011","unstructured":"Bassi R, Fiorina P (2011) Impact of islet transplantation on diabetes complications and quality of life. Curr Diab Rep 11(5):355\u2013363. https:\/\/doi.org\/10.1007\/s11892-011-0211-1","journal-title":"Curr Diab Rep"},{"issue":"3","key":"5568_CR227","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/TP.0b013e31820437f3","volume":"91","author":"DM Thompson","year":"2011","unstructured":"Thompson DM, Meloche M, Ao Z et al (2011) Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy. Transplantation. 91(3):373\u2013378. https:\/\/doi.org\/10.1097\/TP.0b013e31820437f3","journal-title":"Transplantation."},{"issue":"5","key":"5568_CR228","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1097\/TXD.0000000000000581","volume":"2","author":"J Speight","year":"2016","unstructured":"Speight J, Woodcock AJ, Reaney MD et al (2016) Well, I wouldn\u2019t be any worse off, would I, than I am now? A qualitative study of decision-making, hopes, and realities of adults with type 1 diabetes undergoing islet cell transplantation. Transplant Direct 2(5):e72. https:\/\/doi.org\/10.1097\/TXD.0000000000000581","journal-title":"Transplant Direct"},{"issue":"1","key":"5568_CR229","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/MOT.0b013e32834ee700","volume":"17","author":"AC Gruessner","year":"2012","unstructured":"Gruessner AC, Sutherland DER, Gruessner RWG (2012) Long-term outcome after pancreas transplantation. Curr Opin Organ Transplant 17(1):100\u2013105. https:\/\/doi.org\/10.1097\/MOT.0b013e32834ee700","journal-title":"Curr Opin Organ Transplant"},{"issue":"4","key":"5568_CR230","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/SLA.0b013e3181b76d2b","volume":"250","author":"HW Sollinger","year":"2009","unstructured":"Sollinger HW, Odorico JS, Becker YT, D\u2019Alessandro AM, Pirsch JD (2009) One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up. Ann Surg 250(4):618\u2013630. https:\/\/doi.org\/10.1097\/SLA.0b013e3181b76d2b","journal-title":"Ann Surg"},{"issue":"5","key":"5568_CR231","doi-asserted-by":"publisher","first-page":"752","DOI":"10.2337\/dc14-1686","volume":"38","author":"R Lehmann","year":"2015","unstructured":"Lehmann R, Graziano J, Brockmann J et al (2015) Glycemic control in simultaneous islet-kidney versus pancreas-kidney transplantation in type 1 diabetes: a prospective 13-year follow-up. Diabetes Care 38(5):752\u2013759. https:\/\/doi.org\/10.2337\/dc14-1686","journal-title":"Diabetes Care"},{"issue":"2","key":"5568_CR232","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.transproceed.2006.01.005","volume":"38","author":"R Kandaswamy","year":"2006","unstructured":"Kandaswamy R, Sutherland DER (2006) Pancreas versus islet transplantation in diabetes mellitus: how to allocate deceased donor pancreata? Transplant Proc 38(2):365\u2013367. https:\/\/doi.org\/10.1016\/j.transproceed.2006.01.005","journal-title":"Transplant Proc"},{"issue":"Suppl 1","key":"5568_CR233","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.2337\/diacare.27.2007.S105","volume":"27","author":"American Diabetes Association","year":"2004","unstructured":"American Diabetes Association (2004) Pancreas transplantation in type 1 diabetes. Diabetes Care 27(Suppl 1):S105","journal-title":"Diabetes Care"},{"issue":"4","key":"5568_CR234","doi-asserted-by":"publisher","first-page":"955","DOI":"10.2337\/diabetes.53.4.955","volume":"53","author":"EA Ryan","year":"2004","unstructured":"Ryan EA, Shandro T, Green K et al (2004) Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes. 53(4):955\u2013962. https:\/\/doi.org\/10.2337\/diabetes.53.4.955","journal-title":"Diabetes."},{"issue":"4","key":"5568_CR235","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1089\/dia.2014.0289","volume":"17","author":"PA Senior","year":"2015","unstructured":"Senior PA, Bellin MD, Alejandro R et al (2015) Consistency of quantitative scores of hypoglycemia severity and glycemic lability and comparison with continuous glucose monitoring system measures in long-standing type 1 diabetes. Diabetes Technol Ther 17(4):235\u2013242. https:\/\/doi.org\/10.1089\/dia.2014.0289","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"5568_CR236","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1111\/j.1600-6143.2011.03977.x","volume":"12","author":"MD Bellin","year":"2012","unstructured":"Bellin MD, Barton FB, Heitman A et al (2012) Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes. Am J Transplant 12(6):1576\u20131583. https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03977.x","journal-title":"Am J Transplant"},{"issue":"5","key":"5568_CR237","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00592-014-0627-6","volume":"51","author":"M Qi","year":"2014","unstructured":"Qi M, Kinzer K, Danielson KK et al (2014) Five-year follow-up of patients with type 1 diabetes transplanted with allogeneic islets: the UIC experience. Acta Diabetol 51(5):833\u2013843. https:\/\/doi.org\/10.1007\/s00592-014-0627-6","journal-title":"Acta Diabetol"},{"key":"5568_CR238","unstructured":"Clinical Islet Transplantation Consortium (2015) Clinical Islet Transplantation Study. Available from: www.isletstudy.org\/. Accessed 11 February 2021"},{"issue":"7","key":"5568_CR239","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1111\/ajt.12250","volume":"13","author":"PJ O\u2019Connell","year":"2013","unstructured":"O\u2019Connell PJ, Holmes-Walker DJ, Goodman D et al (2013) Multicenter Australian trial of islet transplantation: improving accessibility and outcomes. Am J Transplant 13(7):1850\u20131858. https:\/\/doi.org\/10.1111\/ajt.12250","journal-title":"Am J Transplant"},{"issue":"12","key":"5568_CR240","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1111\/ajt.12469","volume":"13","author":"AM Brooks","year":"2013","unstructured":"Brooks AM, Walker N, Aldibbiat A et al (2013) Attainment of metabolic goals in the integrated UK islet transplant program with locally isolated and transported preparations. Am J Transplant 13(12):3236\u20133243. https:\/\/doi.org\/10.1111\/ajt.12469","journal-title":"Am J Transplant"},{"issue":"7","key":"5568_CR241","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1464-5491.2010.03029.x","volume":"27","author":"J Speight","year":"2010","unstructured":"Speight J, Reaney MD, Woodcock AJ, Smith RM, Shaw JAM (2010) Patient-reported outcomes following islet cell or pancreas transplantation (alone or after kidney) in type 1 diabetes: a systematic review. Diabet Med 27(7):812\u2013822. https:\/\/doi.org\/10.1111\/j.1464-5491.2010.03029.x","journal-title":"Diabet Med"},{"issue":"6","key":"5568_CR242","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.2337\/dc15-0090","volume":"38","author":"P Choudhary","year":"2015","unstructured":"Choudhary P, Rickels MR, Senior PA et al (2015) Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia. Diabetes Care 38(6):1016\u20131029. https:\/\/doi.org\/10.2337\/dc15-0090","journal-title":"Diabetes Care"},{"issue":"7","key":"5568_CR243","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S2213-8587(18)30078-0","volume":"6","author":"S Lablanche","year":"2018","unstructured":"Lablanche S, Vantyghem M-C, Kessler L et al (2018) Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol 6(7):527\u2013537. https:\/\/doi.org\/10.1016\/S2213-8587(18)30078-0","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"5568_CR244","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.tem.2019.11.007","volume":"31","author":"JR Snaith","year":"2020","unstructured":"Snaith JR, Holmes-Walker DJ, Greenfield JR (2020) Reducing type 1 diabetes mortality: role for adjunctive therapies? Trends Endocrinol Metab 31(2):150\u2013164. https:\/\/doi.org\/10.1016\/j.tem.2019.11.007","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"5568_CR245","doi-asserted-by":"publisher","first-page":"e3334","DOI":"10.1002\/dmrr.3334","volume":"36","author":"Y-S Liu","year":"2020","unstructured":"Liu Y-S, Chen C-N, Chen Z-G, Peng Y, Lin X-P, Xu L-L (2020) Vascular and metabolic effects of metformin added to insulin therapy in patients with type 1 diabetes: a systematic review and meta-analysis. Diabetes Metab Res Rev 36(6):e3334. https:\/\/doi.org\/10.1002\/dmrr.3334","journal-title":"Diabetes Metab Res Rev"},{"issue":"8","key":"5568_CR246","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S2213-8587(17)30194-8","volume":"5","author":"JR Petrie","year":"2017","unstructured":"Petrie JR, Chaturvedi N, Ford I et al (2017) Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol 5(8):597\u2013609. https:\/\/doi.org\/10.1016\/S2213-8587(17)30194-8","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"5568_CR247","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s001250050646","volume":"40","author":"MF Kong","year":"1997","unstructured":"Kong MF, King P, Macdonald IA et al (1997) Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM. Diabetologia. 40(1):82\u201388. https:\/\/doi.org\/10.1007\/s001250050646","journal-title":"Diabetologia."},{"issue":"5","key":"5568_CR248","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s001250050949","volume":"41","author":"MF Kong","year":"1998","unstructured":"Kong MF, Stubbs TA, King P et al (1998) The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM. Diabetologia. 41(5):577\u2013583. https:\/\/doi.org\/10.1007\/s001250050949","journal-title":"Diabetologia."},{"issue":"5","key":"5568_CR249","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1053\/meta.2002.32022","volume":"51","author":"MS Fineman","year":"2002","unstructured":"Fineman MS, Koda JE, Shen LZ et al (2002) The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes. Metabolism. 51(5):636\u2013641. https:\/\/doi.org\/10.1053\/meta.2002.32022","journal-title":"Metabolism."},{"issue":"5","key":"5568_CR250","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1007\/s00125-005-1732-4","volume":"48","author":"I Chapman","year":"2005","unstructured":"Chapman I, Parker B, Doran S et al (2005) Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes. Diabetologia. 48(5):838\u2013848. https:\/\/doi.org\/10.1007\/s00125-005-1732-4","journal-title":"Diabetologia."},{"issue":"4","key":"5568_CR251","doi-asserted-by":"publisher","first-page":"724","DOI":"10.2337\/diacare.25.4.724","volume":"25","author":"F Whitehouse","year":"2002","unstructured":"Whitehouse F, Kruger DF, Fineman M et al (2002) A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes. Diabetes Care 25(4):724\u2013730. https:\/\/doi.org\/10.2337\/diacare.25.4.724","journal-title":"Diabetes Care"},{"issue":"1","key":"5568_CR252","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/15209150252924094","volume":"4","author":"RE Ratner","year":"2002","unstructured":"Ratner RE, Want LL, Fineman MS et al (2002) Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetes. Diabetes Technol Ther 4(1):51\u201361. https:\/\/doi.org\/10.1089\/15209150252924094","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"5568_CR253","doi-asserted-by":"publisher","first-page":"784","DOI":"10.2337\/diacare.26.3.784","volume":"26","author":"PA Hollander","year":"2003","unstructured":"Hollander PA, Levy P, Fineman MS et al (2003) Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial. Diabetes Care 26(3):784\u2013790. https:\/\/doi.org\/10.2337\/diacare.26.3.784","journal-title":"Diabetes Care"},{"issue":"11","key":"5568_CR254","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1111\/j.1464-5491.2004.01319.x","volume":"21","author":"RE Ratner","year":"2004","unstructured":"Ratner RE, Dickey R, Fineman M et al (2004) Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in type 1 diabetes mellitus: a 1-year, randomized controlled trial. Diabet Med 21(11):1204\u20131212. https:\/\/doi.org\/10.1111\/j.1464-5491.2004.01319.x","journal-title":"Diabet Med"},{"issue":"4","key":"5568_CR255","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S2213-8587(21)00019-X","volume":"9","author":"M von Herrath","year":"2021","unstructured":"von Herrath M, Bain SC, Bode B et al (2021) Anti-interleukin-21 antibody and liraglutide for the preservation of \u03b2-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Diabetes Endocrinol 9(4):212\u2013224. https:\/\/doi.org\/10.1016\/S2213-8587(21)00019-X","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"5568_CR256","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S2213-8587(20)30043-7","volume":"8","author":"MA Nauck","year":"2020","unstructured":"Nauck MA, Meier JJ (2020) GLP-1 receptor agonists in type 1 diabetes: a MAG1C bullet? Lancet Diabetes Endocrinol 8(4):262\u2013264. https:\/\/doi.org\/10.1016\/S2213-8587(20)30043-7","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"5568_CR257","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.2337\/dc16-0691","volume":"39","author":"C Mathieu","year":"2016","unstructured":"Mathieu C, Zinman B, Hemmingsson JU et al (2016) Efficacy and safety of liraglutide added to insulin treatment in type 1 diabetes: the ADJUNCT ONE treat-to-target randomized trial. Diabetes Care 39(10):1702\u20131710. https:\/\/doi.org\/10.2337\/dc16-0691","journal-title":"Diabetes Care"},{"issue":"10","key":"5568_CR258","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.2337\/dc16-0690","volume":"39","author":"B Ahr\u00e9n","year":"2016","unstructured":"Ahr\u00e9n B, Hirsch IB, Pieber TR et al (2016) Efficacy and safety of liraglutide added to capped insulin treatment in subjects with type 1 diabetes: the ADJUNCT TWO randomized trial. Diabetes Care 39(10):1693\u20131701. https:\/\/doi.org\/10.2337\/dc16-0690","journal-title":"Diabetes Care"},{"issue":"1133","key":"5568_CR259","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/postgradmedj-2019-137186","volume":"96","author":"KH Sheahan","year":"2020","unstructured":"Sheahan KH, Wahlberg EA, Gilbert MP (2020) An overview of GLP-1 agonists and recent cardiovascular outcomes trials. Postgrad Med J 96(1133):156\u2013161. https:\/\/doi.org\/10.1136\/postgradmedj-2019-137186","journal-title":"Postgrad Med J"},{"issue":"11","key":"5568_CR260","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S et al (2021) Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med 384(11):989. https:\/\/doi.org\/10.1056\/NEJMoa2032183","journal-title":"N Engl J Med"},{"issue":"12","key":"5568_CR261","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S2213-8587(19)30154-8","volume":"7","author":"SI Taylor","year":"2019","unstructured":"Taylor SI, Blau JE, Rother KI, Beitelshees AL (2019) SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks. Lancet Diabetes Endocrinol 7(12):949\u2013958. https:\/\/doi.org\/10.1016\/S2213-8587(19)30154-8","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10166","key":"5568_CR262","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","volume":"393","author":"TA Zelniker","year":"2019","unstructured":"Zelniker TA, Wiviott SD, Raz I et al (2019) SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet 393(10166):31\u201339. https:\/\/doi.org\/10.1016\/S0140-6736(18)32590-X","journal-title":"Lancet"},{"issue":"10","key":"5568_CR263","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S2213-8587(20)30280-1","volume":"8","author":"P-H Groop","year":"2020","unstructured":"Groop P-H, Dandona P, Phillip M et al (2020) Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials. Lancet Diabetes Endocrinol 8(10):845\u2013854. https:\/\/doi.org\/10.1016\/S2213-8587(20)30280-1","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"5568_CR264","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.2337\/dc08-2061","volume":"32","author":"DM Jensen","year":"2009","unstructured":"Jensen DM, Korsholm L, Ovesen P, Beck-Nielsen H, Moelsted-Pedersen L, Westergaard JG et al (2009) Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care 32(6):1046\u20131048. https:\/\/doi.org\/10.2337\/dc08-2061","journal-title":"Diabetes Care"},{"issue":"4","key":"5568_CR265","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5694\/mja16.00443","volume":"205","author":"SK Abell","year":"2016","unstructured":"Abell SK, Boyle JA, de Courten B et al (2016) Contemporary type 1 diabetes pregnancy outcomes: impact of obesity and glycaemic control. Med J Aust 205(4):162\u2013167. https:\/\/doi.org\/10.5694\/mja16.00443","journal-title":"Med J Aust"},{"issue":"10110","key":"5568_CR266","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","volume":"390","author":"DS Feig","year":"2017","unstructured":"Feig DS, Donovan LE, Corcoy R et al (2017) Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 390(10110):2347\u20132359. https:\/\/doi.org\/10.1016\/S0140-6736(17)32400-5","journal-title":"Lancet."},{"issue":"1","key":"5568_CR267","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2337\/dc07-1066","volume":"31","author":"LR Nielsen","year":"2008","unstructured":"Nielsen LR, Pedersen-Bjergaard U, Thorsteinsson B, Johansen M, Damm P, Mathiesen ER (2008) Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control. Diabetes Care 31(1):9\u201314","journal-title":"Diabetes Care"},{"issue":"1","key":"5568_CR268","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/AOG.0000000000000060","volume":"123","author":"BM Sibai","year":"2014","unstructured":"Sibai BM, Viteri OA (2014) Diabetic ketoacidosis in pregnancy. Obstet Gynecol 123(1):167\u2013178. https:\/\/doi.org\/10.1097\/AOG.0000000000000060","journal-title":"Obstet Gynecol"},{"issue":"7","key":"5568_CR269","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1055\/s-0036-1571323","volume":"33","author":"HA Roeder","year":"2016","unstructured":"Roeder HA, Moore TR, Ramos GA (2016) Changes in postpartum insulin requirements for patients with well-controlled type 1 diabetes. Am J Perinatol 33(7):683\u2013687. https:\/\/doi.org\/10.1055\/s-0036-1571323","journal-title":"Am J Perinatol"},{"issue":"6684","key":"5568_CR270","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1136\/bmj.298.6684.1357","volume":"298","author":"HA Davies","year":"1989","unstructured":"Davies HA, Clark JD, Dalton KJ, Edwards OM (1989) Insulin requirements of diabetic women who breast feed. BMJ. 298(6684):1357\u20131358. https:\/\/doi.org\/10.1136\/bmj.298.6684.1357","journal-title":"BMJ."},{"key":"5568_CR271","unstructured":"WHO (2015) Medical eligibility criteria wheel for contraceptive use. Available from: www.who.int\/reproductivehealth\/publications\/family_planning\/mec-wheel-5th\/en\/. Accessed 16 July 2021"},{"issue":"Suppl 1","key":"5568_CR272","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.2337\/dc21-S014","volume":"44","author":"American Diabetes Association","year":"2021","unstructured":"American Diabetes Association (2021) 14. Management of diabetes in pregnancy: standards of medical care in diabetes\u20142021. Diabetes Care 44(Suppl 1):S200\u2013S210. https:\/\/doi.org\/10.2337\/dc21-S014","journal-title":"Diabetes Care"},{"key":"5568_CR273","unstructured":"National Institute for Health and Care Excellence (2020) Diabetes in pregnancy: management from preconception to the postnatal period. Available from: www.nice.org.uk\/guidance\/ng3. Accessed 18 February 2021"},{"issue":"3","key":"5568_CR274","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2337\/ds18-0033","volume":"31","author":"E Leung","year":"2018","unstructured":"Leung E, Wongrakpanich S, Munshi MN (2018) Diabetes management in the elderly. Diabetes Spectrum 31(3):245\u2013253. https:\/\/doi.org\/10.2337\/ds18-0033","journal-title":"Diabetes Spectrum"},{"issue":"8856","key":"5568_CR275","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/0140-6736(93)90816-Y","volume":"341","author":"PH Wang","year":"1993","unstructured":"Wang PH, Lau J, Chalmers TC (1993) Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet. 341(8856):1306\u20131309. https:\/\/doi.org\/10.1016\/0140-6736(93)90816-Y","journal-title":"Lancet."},{"issue":"1","key":"5568_CR276","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/ki.2014.128","volume":"87","author":"ME Molitch","year":"2015","unstructured":"Molitch ME, Adler AI, Flyvbjerg A et al (2015) Diabetic kidney disease: a clinical update from kidney disease: improving global outcomes. Kidney Int 87(1):20\u201330. https:\/\/doi.org\/10.1038\/ki.2014.128","journal-title":"Kidney Int"},{"issue":"12","key":"5568_CR277","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.jdiacomp.2017.08.014","volume":"31","author":"G Aleppo","year":"2017","unstructured":"Aleppo G, Calhoun P, Foster NC et al (2017) Reported gastroparesis in adults with type 1 diabetes (T1D) from the T1D Exchange clinic registry. J Diabetes Complicat 31(12):1669\u20131673. https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.08.014","journal-title":"J Diabetes Complicat"},{"issue":"7","key":"5568_CR278","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1001\/archopht.116.7.874","volume":"116","author":"The Diabetes Control and Complications Trial Research Group","year":"1998","unstructured":"The Diabetes Control and Complications Trial Research Group (1998) Early worsening of diabetic retinopathy in the diabetes control and complications trial. Arch Ophthalmol 116(7):874\u2013886. https:\/\/doi.org\/10.1001\/archopht.116.7.874","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"5568_CR279","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/BF00685978","volume":"72","author":"JG Llewelyn","year":"1986","unstructured":"Llewelyn JG, Thomas PK, Fonseca V, King RH, Dandona P (1986) Acute painful diabetic neuropathy precipitated by strict glycaemic control. Acta Neuropathol 72(2):157\u2013163. https:\/\/doi.org\/10.1007\/BF00685978","journal-title":"Acta Neuropathol"},{"issue":"10","key":"5568_CR280","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.2337\/dc14-1720","volume":"37","author":"SD de Ferranti","year":"2014","unstructured":"de Ferranti SD, de Boer IH, Fonseca V et al (2014) Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care 37(10):2843\u20132863. https:\/\/doi.org\/10.2337\/dc14-1720","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"5568_CR281","doi-asserted-by":"publisher","first-page":"S211","DOI":"10.2337\/dc21-S015","volume":"44","author":"American Diabetes Association","year":"2021","unstructured":"American Diabetes Association (2021) 15. Diabetes care in the hospital: standards of medical care in diabetes\u20142021. Diabetes Care 44(Suppl 1):S211\u2013S220. https:\/\/doi.org\/10.2337\/dc21-S015","journal-title":"Diabetes Care"},{"issue":"2","key":"5568_CR282","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2165\/00024677-200302020-00003","volume":"2","author":"GE Umpierrez","year":"2003","unstructured":"Umpierrez GE, Kitabchi AE (2003) Diabetic ketoacidosis: risk factors and management strategies. Treat Endocrinol 2(2):95\u2013108. https:\/\/doi.org\/10.2165\/00024677-200302020-00003","journal-title":"Treat Endocrinol"},{"issue":"6","key":"5568_CR283","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1177\/1932296820954163","volume":"14","author":"RJ Galindo","year":"2020","unstructured":"Galindo RJ, Umpierrez GE, Rushakoff RJ et al (2020) Continuous glucose monitors and automated insulin dosing systems in the hospital consensus guideline. J Diabetes Sci Technol 14(6):1035\u20131064. https:\/\/doi.org\/10.1177\/1932296820954163","journal-title":"J Diabetes Sci Technol"},{"issue":"10","key":"5568_CR284","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s11892-017-0919-7","volume":"17","author":"CE Mendez","year":"2017","unstructured":"Mendez CE, Umpierrez GE (2017) Management of type 1 diabetes in the hospital setting. Curr Diab Rep 17(10):98","journal-title":"Curr Diab Rep"},{"issue":"1","key":"5568_CR285","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4158\/EP.15.1.24","volume":"15","author":"RM Bailon","year":"2009","unstructured":"Bailon RM, Partlow BJ, Miller-Cage V et al (2009) Continuous subcutaneous insulin infusion (insulin pump) therapy can be safely used in the hospital in select patients. Endocr Pract 15(1):24\u201329. https:\/\/doi.org\/10.4158\/EP.15.1.24","journal-title":"Endocr Pract"},{"issue":"6","key":"5568_CR286","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1177\/0145721705281563","volume":"31","author":"CB Cook","year":"2005","unstructured":"Cook CB, Boyle ME, Cisar NS et al (2005) Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital setting: proposed guidelines and outcome measures. Diabetes Educ 31(6):849\u2013857. https:\/\/doi.org\/10.1177\/0145721705281563","journal-title":"Diabetes Educ"},{"issue":"9","key":"5568_CR287","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41574-020-0375-3","volume":"16","author":"GG Nair","year":"2020","unstructured":"Nair GG, Tzanakakis ES, Hebrok M (2020) Emerging routes to the generation of functional \u03b2-cells for diabetes mellitus cell therapy. Nat Rev Endocrinol 16(9):506\u2013518. https:\/\/doi.org\/10.1038\/s41574-020-0375-3","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"5568_CR288","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrd.2016.232","volume":"16","author":"T Desai","year":"2017","unstructured":"Desai T, Shea LD (2017) Advances in islet encapsulation technologies. Nat Rev Drug Discov 16(5):338\u2013350. https:\/\/doi.org\/10.1038\/nrd.2016.232","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"5568_CR289","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.stem.2015.12.002","volume":"18","author":"WT Hendriks","year":"2016","unstructured":"Hendriks WT, Warren CR, Cowan CA (2016) Genome editing in human pluripotent stem cells: approaches, pitfalls, and solutions. Cell Stem Cell 18(1):53\u201365. https:\/\/doi.org\/10.1016\/j.stem.2015.12.002","journal-title":"Cell Stem Cell"},{"issue":"10205","key":"5568_CR290","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/S0140-6736(19)32127-0","volume":"394","author":"CM Dayan","year":"2019","unstructured":"Dayan CM, Korah M, Tatovic D, Bundy BN, Herold KC (2019) Changing the landscape for type 1 diabetes: the first step to prevention. Lancet. 394(10205):1286\u20131296. https:\/\/doi.org\/10.1016\/S0140-6736(19)32127-0","journal-title":"Lancet."},{"issue":"1","key":"5568_CR291","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2337\/dc18-1157","volume":"42","author":"JW Hughes","year":"2019","unstructured":"Hughes JW, Bao YK, Salam M et al (2019) Late-onset T1DM and older age predict risk of additional autoimmune disease. Diabetes Care 42(1):32\u201338","journal-title":"Diabetes Care"},{"issue":"2","key":"5568_CR292","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.eprac.2020.09.012","volume":"27","author":"A Milluzzo","year":"2021","unstructured":"Milluzzo A, Falorni A, Brozzetti A et al (2021) Risk for coexistent autoimmune diseases in familial and sporadic type 1 diabetes is related to age at diabetes onset. Endocr Pract 27(2):110\u2013117. https:\/\/doi.org\/10.1016\/j.eprac.2020.09.012","journal-title":"Endocr Pract"},{"issue":"2","key":"5568_CR293","doi-asserted-by":"publisher","first-page":"95","DOI":"10.7326\/M16-2596","volume":"167","author":"RM Bergenstal","year":"2017","unstructured":"Bergenstal RM, Gal RL, Connor CG et al (2017) Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels. Ann Intern Med 167(2):95\u2013102. https:\/\/doi.org\/10.7326\/M16-2596","journal-title":"Ann Intern Med"}],"updated-by":[{"DOI":"10.1007\/s00125-021-05600-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000}}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-021-05568-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-021-05568-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-021-05568-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T13:24:56Z","timestamp":1699536296000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-021-05568-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":293,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5568"],"URL":"https:\/\/doi.org\/10.1007\/s00125-021-05568-3","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,30]]},"assertion":[{"value":"30 September 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00125-021-05600-6","URL":"https:\/\/doi.org\/10.1007\/s00125-021-05600-6","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}